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 Summary 
 
Synaptic plasticity, the activity-dependent alteration of neuronal synapses, 
underlies learning and memory formation. Local translation of dendritically 
localized mRNAs greatly contributes to this process. The double-stranded RNA-
binding protein, Staufen2 (Stau2) is known to traffic along neuronal dendrites, 
thereby contributing to dendritic messenger RNA (mRNA) transport and local 
translation. To date, however, the precise mechanisms underlying the binding of 
Stau2 to its target mRNAs and hence their post-transcriptional regulation remain 
elusive. The aim of this thesis was to identify Stau2-bound mRNAs from rat brain 
and characterize the role of Stau2 in their post-transcriptional regulation in depth. 
These RNAs were identified either via microarray or individual nucleotide 
resolution CLIP (iCLIP) and deep sequencing in rat brain. The iCLIP results 
demonstrated significant Stau2 binding preferentially to the 3’-UTR region of 356 
mRNAs. For several of these targets, the regulation of mRNA stability, 
localization and finally translation by Stau2 was tested. Two novel Stau2 target 
mRNAs, Calmodulin3 (Calm3) and Regulator of G-Protein signaling 4 (Rgs4), 
localized to dendrites of hippocampal neurons. Both these mRNAs encode for 
proteins essential in neuronal signaling cascades essential in learning and 
memory. Stau2 stabilizes Rgs4 mRNA via its 3’-UTR. On the contrary, Stau2 did 
not affect Calm3 mRNA stability. Instead, I could show that it has a direct role in 
mediating Calm3 dendritic localization emphasizing that Stau2 function might be 
distinct for different target mRNAs. Interestingly, the 3’-UTR of the long isoform of 
Calmodulin3 (Calm3L) mRNA, showed strongest Stau2 binding in its retained 
intronic region. This interaction enabled Stau2 to mediate dendritic localization of 
this Calm3L isoform in mature rat hippocampal neurons. Notably, this localization 
is promoted by N-methyl-D-aspartate (NMDA)-mediated synaptic activation. 
NMDA activates ionotropic glutamate receptors and enhances their conductivity. 
This is now known to be one of the essential elements for the induction of 
synaptic plasticity and thus represents a molecular mechanism for 
learning and memory. We have also identified 27 other Stau2 target mRNAs that 
retain an intron in their 3’-UTRs. This suggests an elegant mechanism wherein 
Stau2 is recruited by selective intron retention in selected target mRNA 3’-UTR, 
which then acts in the neuronal activity-dependent localization of Calm3L mRNA 
to distal dendrites. Furthermore, in the absence of Stau2 the Calm3L isoform 
accumulates in the nucleus in hippocampal neurons. This introduces a new role 
for Stau2 (which is known to shuttle between nucleus and cytoplasm), in nuclear 
export. 
Together, this work identifies mRNA targets directly bound by Stau2 in neurons 
and along with the in depth analysis of these targets yields important insights into 
the specificity and underlying mechanisms of Stau2 function in synaptic plasticity. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Zusammenfassung 
 
Synaptische Plastizität, der funktionelle und strukturelle Umbau von Synapsen in 
Abhängigkeit neuronaler Aktivität, ist die Grundlage des Lernens und der 
Entstehung von Erinnerungen. Die dendritische Lokalisation von mRNA und 
deren anschließender Translation an der Synapse tragen zu diesem Prozess bei. 
Das Doppelstrang-RNA-Bindeprotein Staufen2 (Stau2) wird dabei in einem RNA-
Proteinkomplex entlang neuronaler Dendriten transportiert und trägt so zum 
mRNA Transport und zu der lokalen Translation in Dendriten bei. Bis heute ist 
der zugrundeliegende Mechanismus der Interaktion zwischen Stau2 und dessen 
Ziel-mRNAs sowie deren post-transkriptionelle Regulation nicht geklärt. Ziel 
dieser Dissertation war die Identifizierung Stau2-gebundener neuronaler mRNAs 
und die Charakterisierung der Stau2-abhängigen post-transkriptionellen 
Regulation dieser mRNAs. Die Identifizierung von Ziel-mRNAs im Nagerhirn 
erfolgte mittels microarray bzw. iCLIP (individual nucleotide resolution CLIP) in 
Kombination mit deep sequencing. Die iCLIP Ergebnisse zeigten eine 
signifikante Anreicherung von Stau2-Bindestellen in 356 mRNAs, bevorzugt in 
deren 3’-UTR. Für zwei der identifizierten mRNAs wurde die Stau2-abhängige 
Regulation der mRNA Stabilität, Lokalisation und Translation getestet. Diese 
Stau2 Ziel-mRNAs, Calmodulin3 (Calm3) und Regulator of G-Protein signaling 4 
(Rgs4), sind in den Dendriten hippocampaler Neuronen lokalisiert. Beide 
Transkripte codieren für Proteine, die eine wesentliche Rolle in einer neuronalen 
Signalkaskade einnehmen, welche für das Lernen und die Gedächtnisbildung 
essentiell ist. Stau2 stabilisiert die Rgs4 mRNA über deren 3’-UTR. Im 
Gegensatz dazu hat Stau2 keinen Einfluss auf die Stabilität der Calm3 mRNA, 
sondern übt eine direkte Rolle aus auf deren dendritische Lokalisation. Dies 
zeigt, dass Stau2 im Bezug auf unterschiedliche Ziel-mRNAs unterschiedliche 
Funktionen haben könnte. 
Interessanterweise wurde die stärkste Bindung von Stau2 an ein nicht 
gespleißtes Intron in der 3’-UTR der langen Isoform von Calmodulin3 (Calm3L) 
nachgewiesen. Durch diese Interaktion mit Stau2 wird die dendritische 
Lokalisation der Calm3L Isoform in hippocampalen Neuronen gewährleistet. 
Interessanterweise fördert die N-Methyl-D-Aspartat (NMDA) vermittelte 
synaptische Aktivität diese Lokalisation in Dendriten. NMDA aktiviert ionotrope 
Glutamatrezeptoren und steigert deren Konduktivität. Dies ist einer der 
essentiellen Prozesse, die zur Induktion synaptischer Plastizität führen, und stellt 
daher einen molekularen Mechanismus für das Lernen und die Bildung von 
Erinnerungen dar. Zusätzlich wurden 27 weitere Stau2 Ziel-mRNAs identifiziert, 
die ein Intron in ihrer 3’-UTR beibehalten. Dies deutet auf einen Mechanismus 
hin, bei dem Stau2 durch selektiv beibehaltene Introns in bestimmten 3’-UTRs 
rekrutiert werden kann. Dieser Prozess führt zur aktivitäts-abhängigen 
Lokalisation vom Calm3L mRNA in distalen Dendriten. In Abwesenheit von Stau2 
akkumuliert die Calm3L Isoform im Zellkern hippocampaler Neuronen. Es ist 
bekannt, dass Stau2 zwischen Nukleus und Zytoplasma transportiert wird. Diese 
Daten deuten somit auf eine bisher unbekannte Funktion von Stau2 im Export 
von mRNAs aus dem Zellkern.  
Zusammenfassend wurden in dieser Doktorarbeit Ziel-mRNAs identifiziert, die 
direkt von Stau2 in Neuronen gebunden werden. Die detaillierte Analyse dieser 
mRNAs liefert wichtige Erkenntnisse über den Beitrag von Stau2 zu der 
synaptischen Plastizität.  
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Introduction 
 
The human brain consists of gigantic neural networks that perform high-end 
tasks from memory formation to behavior control. Effective execution of these 
functions is heavily dependent on the precise modulation of individual neurons 
thereby achieving a dynamic balance between the long-term storage of information 
and plasticity in response to experience. One of the mechanisms underlying this 
process is mRNA localization and local translation at synapses. This is achieved 
through coordinated actions of RNA-binding proteins (RBPs) and regulatory non-
coding RNAs, which direct the fate of mRNAs via nuclear export, mRNA stability, 
transport, and translational control. This thesis explores the specificity of the 
molecular interactions between the RBP Staufen2 (Stau2) and its target mRNAs in 
single neurons and the mechanisms of Stau2-mediated post-transcriptional 
regulation of these mRNAs that underlie the observed synaptic plasticity. 
 
1. mRNA regulation in neurons 
One of the most remarkable characteristics of neurons is their large-scale usage 
of post-transcriptional mRNA regulation to achieve distinct functions, such as axon 
guidance and synaptic plasticity.  In comparison to other cell types, they express a 
wider range of alternatively spliced mRNAs, microRNAs and small RNAs.  Several 
studies have recently demonstrated a clear link between neurological diseases such 
as epilepsy and schizophrenia, and defective RNA regulation (Tolino et al., 2012; 
Wang et al., 2016).  Thus, neurons present a perfect system to understand novel 
concepts of RNA regulation.  
 
1.1 RNA localization  
Neurons harbor morphological and functional polarity. They contain several 
compartments; a cell body, a single branched axon and many highly branched 
dendrites. Each compartment serves a special function. The dendrites can form up to 
several thousand synaptic contacts with neighboring cells from which they receive 
positive or negative stimuli. These stimuli then reach the cell body wherein they are 
consolidated, and a single axon delivers a binary output to post-synaptic neurons 
(Spruston, 2008). The asymmetric distribution of cellular components establishes this 
~Introduction~ 
 
	 2	
cellular polarity; a process essential for development and functioning of mature 
neurons. The prompt and local modulation of subcellular domains in response to 
stimulation is critical to the working of neuronal networks. One well-known 
mechanism that neurons use to create and maintain this asymmetry is the 
localization of subsets of mRNAs to specific domains of the cell and then their local 
translation (Martin and Ephrussi, 2009). This allows stringent temporal and spatial 
control of gene expression, which is used in neurons to achieve synapse-specific 
modifications during learning and memory formation (Martin and Ephrussi, 2009).  
 
1.2. mRNA-RBP interactions in synaptic plasticity 
Synaptic plasticity is the capacity of neurons to modify their synaptic strength, in 
response to usage (Costa-Mattioli et al., 2009) either in the form of long-term 
potentiation (LTP) or long-term depression (LTD). The formation of LTP occurs in two 
temporal phases: 1. Early LTP (E-LTP) induced by one stimulus, that depends on the 
modification of pre-existing proteins rather than new protein synthesis and lasts up to 
several hours; 2. Late LTP (L-LTP) induced by repetitive stimulation that persists for 
more than 8 hours, and requires transcription and new protein synthesis (reviewed by 
(Costa-Mattioli et al., 2009; Sutton and Schuman, 2006)). This two-step process of 
synapse modification is termed ‘synaptic tagging and capture’ (Doyle and Kiebler, 
2011; Martin and Kosik, 2002; Redondo and Morris, 2011). For decades it is known 
that mRNAs, ribosomes and translation factors localize to dendrites (Bodian, 1965; 
Poon et al., 2006; Steward and Levy, 1982). The first evidence that linked local 
mRNA translation to synaptic function came from the study by (Kang and Schuman, 
1996). They showed that brain-derived neurotrophic factor (BDNF)-dependent LTP in 
the hippocampus, is blocked by protein synthesis inhibitors. Interestingly, this protein 
synthesis can even be blocked in dendrites that had been surgically isolated from the 
cell body. There is now little doubt that RNA localization and hence local translation 
contributes to certain forms of synaptic plasticity (Costa-Mattioli et al., 2009; Sutton 
and Schuman, 2006). Many mRNAs encoding proteins e.g. β-actin, the α-subunit of 
the Calcium/calmodulin protein kinase II (CaMKIIα) (Osten et al., 1996) and a 
number of RBPs like the Fragile X mental retardation protein (FMRP), cytoplasmic 
polyadenylation-element-binding protein 1 (CPEB1), zipcode-binding protein 1 
(ZBP1) and Staufen proteins localize to distal dendrites. These RBPs have been 
implicated in the transport and translational control of dendritically localized mRNAs. 
~Introduction~ 
 
	 3	
In addition to the role of local translation in dendrites, local translation of mRNAs is 
also important in axons, particularly during axon guidance and synapse formation. 
Local translation of cytoskeletal components, such as β-actin, RhoA and MAP1b 
regulates the structure of the growth cone (Hengst and Jaffrey, 2007). The most 
established case for local translation in axons is that of β-actin mRNA and its 
regulation by ZBP1 (Sasaki et al., 2010). Regulation of local β-actin protein synthesis 
is an important mediator of the response of the axon growth cones to external cues. 
mRNA function in neurons can be regulated at several steps; (1) nuclear export 
of the mRNA; (2) mRNP formation and maturation (3) mRNP transport and 
anchoring; (4) mRNA translational control; and finally (4) mRNA stability. Neuronal 
activity is now known to affect these individual steps. The model for activity 
dependent RNA localization in neurons is outlined in Figure 1. RNAs transcribed and 
spliced in the nucleus are packaged with RBPs to form ribonucleoprotein particles 
(RNPs) in the cell body. This process can already take place in the nucleus. RNPs 
are then transported to dendrites along the microtubule network (Ferrandon et al., 
1994). mRNAs that are translationally silent may be anchored close to synapses or 
continuously traffick until they are recruited to an active synapse as proposed in the 
sushi belt model (Doyle and Kiebler, 2011). Neuronal stimulation of a given synapse 
may lead to increased dendritic transport and/or the unpackaging of that mRNA 
followed by local translation. The protein produced as a result can then contribute to 
either structural, modifications e.g. the insertion of more neurotransmitter receptors 
into the plasma membrane, or molecular modification e.g. production of a signaling or 
cytoskeletal molecule at the synapse (Doyle and Kiebler, 2011). This activity-
dependent modification of dendritic spines constitutes a form of structural plasticity 
that is contributed by the local translation of synaptic proteins. 
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Figure 1 Model for mRNP formation, dendritic localization and local mRNA translation 
in neurons: RBPs bind to specific mRNA targets by binding to distinct localization elements 
(LEs), wherein they are assembled into diverse mRNPs. Here the small black boxes 
represent LEs that are primary sequence element; while stem-loops indicate LEs that 
represent conserved secondary structures. mRNP maturation is a complex process: it can 
occur before the actual translocation process starts or during transport along microtubules. 
The mRNPs then could be locally anchored at synapses or they keep translocating in a 
circular fashion like in a sushi-belt. Upon unmasking, proteins bound to the mRNA dissociate 
from the mRNP leading to the bound mRNA being accessible to ribosomes for subsequent 
translation. Finally, after translation is done the mRNA will either be degraded at the site of 
translation or repackaged into an mRNP (taken from Hutten, Sharangdhar and Kiebler 
2014). 
 
1.3. 3’-Untranslated region (3’-UTR) – hub of RBP regulation  
Historically, the central dogma asserted a very simplistic model, wherein a gene 
transcribed into a unique single “messenger” molecule or mRNA conveys the 
information to cytoplasmic ribosomes, in order to generate a functional protein by 
translation. After decades of research in the field it is now clear that this process 
shows enormous complexity brought by the generation of diverse mRNA isoforms 
generated post-transcriptionally, depending on the cellular context. Cells that have 
the same DNA code can therefore generate different mRNAs, which either results in 
different protein isoforms, or in distinct mRNA isoforms that encode the same open 
reading frames (ORF) but have different regulatory regions (UTRs). In recent years, 
3’-UTR function has gained importance especially in encoding neuronal functions 
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(Mayr, 2016). By controlling the length of a 3’-UTR, neurons generate mRNA 
isoforms with longer 3’-UTR sequences. These new 3’-UTRs now harbor new binding 
sites for specific RBPs, microRNAs, amongst others. 3’-UTR lengthening can be 
achieved by alternate splicing of the last exon, intron retention or alternate 
polyadenylation (Figure 2).   
 
1.4 Intron Retention  
Most of the introns occur within the ORF, although approximately 10% have been 
identified in UTRs. For a long time, introns have been considered as junk DNA that 
lies within a transcript and needs to be spliced out in the nucleus to obtain a 
functional mRNA that can be translated in the cytoplasm. Intron retention was thus 
considered an error in splicing. The link between these introns and the nonsense 
mediated decay (NMD) pathway strengthened this view (Nagy and Maquat, 1998; 
Zhang et al., 1998). In the NMD pathway, the exon junction complex (EJC) is placed 
20-24 nucleotides upstream of the exon junction once the spliceosome removes an 
intron from the precursor mRNA, marking the place where the intron was spliced out 
(Ji and Tian, 2009). Throughout the export of the mRNA from the nucleus and its 
cytoplasmic transport, the EJC remains tightly bound to it (Di Giammartino et al., 
2011). After the first round of translation, the EJC is displaced by the ribosomes 
moving along the mRNA (Nagy and Maquat, 1998). An EJC downstream of the 
termination of translation would persist in the messenger and activate NMD (Zhang 
et al., 1998). This is a mechanism that ensures elimination of potentially harmful 
truncated proteins, since premature termination codons (PTC) are frequently present 
at the beginning of intronic sequences (Le Hir et al., 2000). Hence the retention of 
introns in the 3’-UTR opens new questions. Studies in recent years have shown that 
these retained introns within coding sequences (CDSs) or UTRs mediate significant 
and distinctive roles in the neuronal gene regulation (Mauger et al., 2016). The 
presence of constitutive introns within the 3’-UTR leads to the degradation of mRNAs 
shortly upon their translation thereby reducing ‘noise’ (Bono and Gehring, 2011). On 
the other hand, retained introns can contain binding elements important for RBP-
dependent localization of the transcript (Buxbaum et al., 2014). With this novel view, 
retained introns in the 3’-UTR could now be regarded as important cis-regulatory 
elements that can help regulate gene expression at several levels.  
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Figure 2: 3’-UTR dependent mRNA diversity necessary for mRNA regulation in 
neurons: The differential mRNA localization, stability and translation in the soma (depicted in 
green) versus the neuronal processes (in pink) is achieved via the generation of a variety of 
mRNA isoforms that only differ in their 3’-UTR sequences. This is achieved either by (A) 
alternative polyadenylation (APA) or by (B) alternative splicing (AS) of the last exons. 
Transcripts with short 3’-untranslated regions (UTRs) are highly stable and generally localize 
in the soma, while transcripts with long 3’-UTRs show lower stability and localize to neuronal 
processes (Lianoglou et al., 2013; Shigeoka et al., 2016), where they can be locally 
translated. Elongation of 3’-UTRs leads to the generation of binding sites for trans-acting 
factors, e.g. RBPs, in extended 3’-UTR (Taliaferro et al., 2016). (C) Furthermore, levels of 
expression of the transcripts with retained introns can be regulated by their interaction with 
the exon junction complex (EJC). Premature termination codons generated due to the 
inclusion of introns in the coding sequence, are usually degraded by the nonsense mediated 
decay (NMD) pathway. Intron retention (IR) in the 3’-UTR can also lead to recruitment of 
specific RBPs that localize mRNA to neural processes. (D) A subset of mRNAs is stored in 
the nucleus by stable IR. Excision of the intron from the unspliced mRNA is induced by 
neuronal activation. Mature mRNA exported to the cytoplasm is then available for translation 
(Mauger et al., 2016). Local translation of transcripts at the synapses (in pink) is then 
activated by neuronal stimulation. (Taken from Fernández-Moya et al., 2017). 
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2. Staufen2 
Staufen has a well-documented function in mRNA localization in the 
development of the Drosophila oocyte (St Johnston, 2005). Also, in Drosophila neural 
precursors, Staufen mediates the asymmetric localization of prospero mRNA to only 
one daughter cell leading to its fate as a ganglion mother cell (Knoblich, 2008). 
Furthermore, Vessey et al., 2012 showed that the Staufen-dependent asymmetric 
localization of prospero in neural precursors is conserved in mammals. Mammals 
have two homologs of the Drosophila Staufen; Staufen 1 (Stau1) and Staufen 2 
(Stau2). Stau2 is expressed mainly in the brain. Stau1, however, is expressed in 
many types including neurons (Duchaîne et al., 2002). Stau1 and Stau2 also play an 
important role in early zebrafish development, where both are involved in the 
migration of primordial germ cells. However, only Stau2 is essential for survival of 
neurons in the central nervous system (Ramasamy et al., 2006). Importantly, the two 
proteins are mostly present in different ribonucleoprotein particles in neuronal 
dendrites. This implies that they have different roles in neurons (Duchaîne et al., 
2002).  
In hippocampal neurons, downregulation of Stau2 decreased the number of 
neuronal synapses (Goetze et al., 2006) that in turn reduced the amplitude of 
miniature excitatory post-synaptic current (mEPSC). These results imply a defect in 
synaptic transmission through post-synaptic glutamate receptors in the absence of 
Stau2. In mature neurons, Stau2 is also required for mGlu-R dependent long-term 
depression (LTD) (Lebeau et al., 2011). The sections below discuss the molecular 
basis of Stau2 function in further detail. 
 
2.1 Stau2 in RNA transport and anchoring 
Although it has been clearly demonstrated that Staufen is involved in RNA 
localization in Drosophila, it remains unclear whether mammalian Stau2 is directly 
involved in the transport of its target mRNAs. Many of the best-characterized models 
of RNA localization have been in Drosophila oocyte development, where differentially 
localized RNAs determine cell fate. Staufen mediates the localization of two of these 
RNAs, bicoid and oskar (St Johnston et al., 1991). Oskar mRNA fails to localize 
correctly in Stau mutant embryos. Staufen is required for both the localization and the 
maintenance of oskar mRNA at the posterior pole (Mhlanga et al., 2009; Rongo et 
al., 1995; Zimyanin et al., 2008). Interestingly, it was found that Staufen is associated 
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with the dynein motor together with bicoid mRNA when localizing to the anterior pole 
of the Drosophila oocyte, during late stages of transport (Weil et al., 2010).  
In neurons, a role of Stau2 in RNA localization has been indicated by studies in 
both Aplysia and rodents. In Aplysia sensory neurons, Staufen accumulates with the 
syntaxin mRNA at the opposite side of the cell body to the axon hillock in untreated 
cells, but then moves to the axon hillock with syntaxin mRNA in response to 
serotonin treatment (Liu et al., 2006). Using a dominant negative Stau2 isoform, 
(Tang et al., 2001) suggested a role of Stau2 in mRNA localization in mammalian 
neurons. But, the specificity and the direct interaction of Stau2 with certain mRNAs 
mediating their dendritic localization remained in question. In this thesis, in 
publication I (Sharangdhar et al., 2017) I could clearly show that Stau2 directly 
affects the localization of one of its target mRNA Calmodulin3 (Calm3) in neuronal 
dendrites in a neuronal activity dependent manner. 
 
2.2 Stau2 in mRNA stability 
Several studies have implicated Stau2 in regulation of mRNA stability. It also 
interacts with Upf1 a regulator of non-sense mediated mRNA decay (Fritzsche et al., 
2013; Graber et al., 2017; Miki et al., 2011). However, Stau2 tethering assays do not 
induce Upf1-dependent mRNA decay in HeLa cells (Miki et al., 2011). This suggests 
that the Stau2-Upf1 interaction has a different function. Knockdown of Stau2 in 
primary hippocampal neurons leads to a reduction in β-actin, MAP2, and α- and β-
tubulin mRNAs (Goetze et al., 2006; Miki et al., 2011). The mechanism that mediate 
Stau2-dependent mRNA stability remains unknown. The experimental data 
presented in publication II (Heraud-Farlow et al., 2013) here show direct links 
between Stau2 and the stability of a subset of its mRNA targets. Several mRNA 
targets e.g. Complexin1, Rgs4, etc are downregulated in the absence of Stau2 in 
hippocampal neurons. However, this subset accounts only for 3.2% of the identified 
Stau2 targets. This suggests that the role of Stau2 is not limited to the regulation of 
mRNA stability.  
 
2.3 Role of Stau2 in the Nucleus 
It is known that under certain conditions Stau2 shuttles between the nucleus 
and cytoplasm (Macchi et al., 2004). In mammalian cells, mutations in the dsRBD3 of 
Stau2 render it incapable of RNA binding causing the protein to accumulate in the 
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nucleolus (Macchi et al., 2004). The nuclear import is mediated via a bipartite NLS 
located between the dsRBD3 and dsRBD4. The 59kDa isoform (Stau259) can be 
exported by the Crm1 (Exportin-1) pathway, while the 62kDa isoform of Stau2 
(Stau262) is exported from the nucleus via an Exportin-5 dependent pathway (Macchi 
et al., 2004; Miki and Yoneda, 2004). However, wild type Stau2 protein is localized in 
the cytoplasm under normal conditions. It has been hypothesized that the NLS of 
Stau2 is unmasked in the absence of RNA (as in the Stau2 RNA binding mutants). 
This allows its interaction with the nuclear import machinery. Once in the nucleus, 
Stau2 could then interact with target RNAs to be exported together. Also, the data 
presented here in Publication I (Sharangdhar et al., 2017) clearly shows that Stau2 
downregulation in hippocampal neurons leads to accumulation of the Calm3L isoform 
in the nucleus. This further supports the theory of origin of Stau2 RNPs in the 
nucleus and would be consistent with mechanisms described for some other RBPs 
involved in RNA localization (Giorgi and Moore, 2007). 
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Publication I 
 
This section includes the work published in EMBO reports (2017), entitled  “A 
retained intron in the 3’-UTR of Calm3 mRNA mediates its Staufen2- and 
activity-dependent localization to neuronal dendrites” by  
Tejaswini Sharangdhar; Yoichiro Sugimoto; Jacqueline Heraud-Farlow; 
Sandra M. Fernández-Moya; Janina Ehses; Igor Ruiz de los Mozos; Jernej Ule; 
Michael A. Kiebler. EMBO reports Aug, 2017. doi:10.15252/embr.201744334 
 
Author contributions to this publication 
 
Tejaswini Sharangdhar contributed to the design of the project and carried out 
the experiments presented in the following figures: Fig 1D, 1E, 1F, 1G; Fig 2; Fig 
3; Fig 4, Fig EV1D, Fig EV2, Fig EV3 and Fig EV4 and also analyzed the data in 
these experiments.  
Yoichiro Sugimoto contributed to the Stau2 iCLIP data generation and analysis in 
Fig1C. Jacqueline Heraud-Farlow performed the Stau2 Immunoprecipitation (IP) 
experiments in Fig1B. Sandra M. Fernandez-Moya performed the northern blots 
in Fig. EV1B; Janina Ehses performed qRT-PCRs in fig 1H and they together 
with Tejaswini Sharangdhar analysed data in Fig3E. Igor Ruiz De Loz Mozos 
analyzed data for Fig1A and EV1A. Jernej Ule supervised the Stau2 iCLIP 
experiments and Michael Kiebler supervised the project and the collaboration.  
The manuscript was written together by Tejaswini Sharangdhar and Michael 
Kiebler. 
 
 
 
Scientific Report
A retained intron in the 30-UTR of Calm3 mRNA
mediates its Staufen2- and activity-dependent
localization to neuronal dendrites
Tejaswini Sharangdhar1, Yoichiro Sugimoto2,3, Jacqueline Heraud-Farlow4,†, Sandra M
Fernández-Moya1, Janina Ehses1, Igor Ruiz de los Mozos2,3 , Jernej Ule2,3 & Michael A Kiebler1,*
Abstract
Dendritic localization and hence local mRNA translation contributes to
synaptic plasticity in neurons. Staufen2 (Stau2) is a well-known
neuronal double-stranded RNA-binding protein (dsRBP) that has been
implicated in dendriticmRNA localization. The specificity of Stau2 bind-
ing to its target mRNAs remains elusive. Using individual-nucleotide
resolution CLIP (iCLIP), we identified significantly enriched Stau2 bind-
ing to the 30-UTRs of 356 transcripts. In 28 (7.9%) of those, binding
occurred to a retained intron in their 30-UTR. The strongest bound 30-
UTR intron was present in the longest isoform of Calmodulin 3 (Calm3L)
mRNA. Calm3L 30-UTR contains six Stau2 crosslink clusters, four of
which are in this retained 30-UTR intron. The Calm3LmRNA localized to
neuronal dendrites, while lack of the 30-UTR intron impaired its
dendritic localization. Importantly, Stau2mediates this dendritic local-
ization via the 30-UTR intron, without affecting its stability. Also,
NMDA-mediated synaptic activity specifically promoted the dendritic
mRNA localization of the Calm3L isoform, while inhibition of synaptic
activity reduced it substantially. Together, our results identify the
retained intron as a critical element in recruiting Stau2, which then
allows for the localization of Calm3LmRNA to distal dendrites.
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Introduction
Dendritic mRNA localization enables neurons to alter the synaptic
proteome thereby inducing plastic changes at selected synapses [1].
In this multi-step process, a selected set of RNA-binding proteins
(RBPs) assembles mRNAs containing cis-acting sorting signals into
ribonucleoprotein particles (RNPs) that are then transported along
the cytoskeleton into dendrites, near synapses [2]. Specific regula-
tion of local mRNA translation at synapses in response to synaptic
stimuli then allows long-term synaptic plasticity, the cellular basis
for learning and memory. Moreover, several other aspects of mRNA
regulation, from nuclear RNA splicing to mRNA stability, play
crucial roles in the adaptation of the synaptic proteome that is
required to maintain synaptic homeostasis [3]. Several studies have
recently reported extensive alternative splicing in neurons [4].
Furthermore, alternative polyadenylation in neurons leads to a vari-
ety of mRNA isoforms of the same transcript differing only in their
30-UTR length [5]. Together, these phenomena give rise to mRNAs,
all expressing the same polypeptide, but harboring additional regu-
latory elements that recruit the neuronal RBPs necessary for fine
post-transcriptional regulation [3,4].
Staufen2 (Stau2) is a well-known neuronal double-stranded
RBP (dsRBP) involved in asymmetric cell division of neural
progenitor cells and has been implicated in dendritic RNA local-
ization, in mature hippocampal neurons [6–9]. Previously, we
identified a repertoire of physiologically relevant target mRNAs
from neuronal Stau2-containing RNA granules [10]. For some of
these targets (e.g., Rgs4, Cplx1), Stau2 influences their mRNA
stability. However, only 38 of the 1,169 Stau2 targets identified
by Stau2 IP (3.2%) show changes in mRNA levels upon Stau2
downregulation [10]. Thus, Stau2 function is not restricted to
regulation of mRNA stability.
It is unclear how Staufen proteins bind to their target mRNAs
with the observed specificity, with several studies coming to dif-
ferent conclusions [11,12], and even some studies suggesting its
binding to be non-sequence-specific [8]. Hence, we applied individual-
nucleotide resolution CLIP (iCLIP) [13] as this yields information
about the direct Stau2 binding to its mRNA targets with higher
resolution compared to Stau2 IP microarray experiments previously
performed [10]. This approach allowed us to uncover significant
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Stau2 binding to 30-UTRs of 356 mRNAs, and 28 of these retained
an intron in their 30-UTR. The strongest Stau2 binding within a
retained intron was seen in the 30-UTR of the longest isoform of
Calmodulin 3 (Calm3L) transcript. Interestingly, Calm3L is the top
target identified by both iCLIP and Stau2 IP microarray. Further-
more, we showed that Calm3L mRNA localized to dendrites in
hippocampal neurons and that NMDA-mediated neuronal
activation specifically promoted dendritic localization of the
intron-containing Calm3L mRNA. Importantly, neither neuronal
activation/silencing nor Stau2 knockdown showed any changes in
total Calm3 mRNA levels. We then set out to investigate a direct
role of Stau2 in dendritic mRNA localization of Calm3L. Finally,
we demonstrated that the recruitment of Stau2 to the Calm3L
mRNA allows its dendritic localization.
Results and Discussion
iCLIP reveals specific binding of Stau2 to Calm3 mRNA via a
retained intron
In order to get a mechanistic insight into Stau2 binding to mRNAs,
we performed iCLIP experiments. We immunoprecipitated the
endogenous Stau2-RNA complexes from embryonic day 18 (E18)
mouse brains by using an antibody against Stau2 (Dataset EV1). IPs
using a rabbit pre-immune serum (PIS) were done in parallel as
negative control. We compared our results with the iCLIP data of
other two RBPs (TDP-43 and FUS) that were also produced from
E18 mouse brains [14]. Here, we identified significant Stau2 binding
in 30-UTRs of 356 neuronal mRNAs (Table EV1). For 28 of these,
the binding sites in 30-UTRs were found in the retained introns
(Fig 1A; Table EV2). Figure EV1A shows three examples of such
mRNAs with Stau2 binding sites within a retained 30-UTR intron.
Among these, Calm3 mRNA stood out as the top Stau2 mRNA target
with a retained 30-UTR intron and with 0.24% of all iCLIP tags on
mRNAs originating from Calm3. This binding was specific for
Calm3 transcripts, but not the other calmodulin orthologs (Calm1,
Calm2) [15], that do not contain any crosslink clusters. This was
confirmed by IP experiments: Only Calm3 transcripts were highly
enriched in the immunoprecipitates of Stau2-containing RNPs
(Fig 1B) [10], but no enrichment was obtained with control PIS IPs.
In rat brain, three mRNA isoforms of Calm3 have been reported,
which differ in their 30-UTR length [15]. In primary rat cortical
neurons, we only observed the presence of two isoforms
(Fig EV1B), the longest of which (Calm3L) contains a retained
intron in its 30-UTR. Our iCLIP analysis revealed that the Calm3
mRNA contains six high-confidence crosslink clusters in the 30-UTR
of the Calm3L isoform, four of which overlapped with the retained
intron (Fig 1C, upper panel). The lower panel in Fig 1C shows the
specific positions of these Stau2 crosslink clusters on a predicted
structure of the Calm3L 3
0-UTR. These positions were located right
next to the long-range predicted RNA duplexes. The cluster with
most crosslinking (cluster 2) was located next to a predicted long-
range duplex, which bridged regions of 30-UTR that are  700 nt
apart. This observation is in agreement with the previous finding
that long-range duplexes in 30-UTRs of mRNAs are enriched on
Stau1 binding sites [16]. Importantly, no high-confidence crosslink
clusters were detected in other intronic regions of Calm3 transcript
(data not shown).
The expression of Calm3L isoform increased with the develop-
ment of in vitro-cultured hippocampal (Figs 1G and EV1D) and rat
cortical neurons (RCN) (Figs 1H and EV1C) and reached maximal
levels in mature neurons that have undergone synaptogenesis (stage
5 neurons; see [17]). Calm3L mRNA localizes mainly in the somato-
dendritic compartment. Also, its localization was restricted to the
MAP2-positive neuronal processes (i.e., dendrites) but not to the
MAP2-negative ones (Fig 1D and F). Importantly, Stau2 co-localized
with the Calm3L mRNA endogenously (Fig 1E).
Synaptic activity regulates Calm3 mRNA localization via the
retained 30-UTR intron in hippocampal neurons
Localization of an mRNA to dendrites can lead to its local transla-
tion and hence spatio-temporal regulation of its function. This local-
ization is known to be influenced by neuronal activity [18].
Therefore, we analyzed the effect of neuronal activation and
▸Figure 1. The intron-containing Calm3 mRNA isoform interacts with Stau2 and localizes to dendrites.A The proportion of cDNAs (out of all cDNAs that mapped to the mouse genome) produced by iCLIP (using E18 mouse brain extracts) from the FUS, TDP-43, and Stau2
experiments that mapped to different RNA regions (i.e., UTR: untranslated region; CDS: coding sequence) and intergenic regions (i.e., non-annotated transcripts).
B Relative values of Calm3, Calm2, and Calm1 mRNA enrichment upon control or anti-Stau2 IPs from E17.5 rat brains. Pre-immune serum was used to perform control
IPs; n = 3, average + SEM.
C iCLIP results show that Stau2 specifically binds to the longest Calm3 (Calm3L) isoform retaining an intron in its 30-UTR (schematic in the middle). Lower panel shows
the specific positions of these Stau2 crosslink clusters on a predicted structure of the Calm3L mRNA.
D Representative images of endogenous Calm3L mRNA in rat primary hippocampal neurons (DIV15) visualized by a FISH probe directed against the intron (Calm3 intron
FISH; red). Magnified insets (40-lm dendritic sections) below identify MAP2-positive (box 1; MAP2 in green) and MAP2-negative (box 2) neuronal processes;
arrowheads indicate the FISH signal for Calm3L mRNA in the dendritic section; nucleus (DAPI; blue). Boxes on the top right show images of bright field (above) and
(below) Stau2 (purple) co-staining with DAPI (cyan); asterisk denotes the soma of the neuron under study; scale bar, 20 lm.
E Co-localization of endogenous Stau2 with endogenous Calm3L mRNA in the panel represented in (D). Arrowheads indicate dendritic co-clusters (Calm3 intron FISH;
green) and Stau2 immunostaining (purple); inset (top right) shows Stau2 staining in the soma at low exposure. The white perforated line marks the position of the
nucleus; scale bar, 20 lm.
F Quantification of the number of spots of Calm3L mRNA per length (40-lm region) in MAP2-positive and MAP2-negative neuronal processes; average + SEM taken
from three independent experiments (30 dendrites each), ***P < 0.001, unpaired Mann–Whitney U-test.
G Quantification of the cell body intensity normalized to area to measure levels of Calm3L mRNA in different stages of in vitro development of rat hippocampal neurons
(1, 4, 8, 12, and 15 DIV), n = 3, average + SEM, t-test; *P < 0.05, **P < 0.01.
H qRT–PCR experiments to measure the relative levels of Calm3L to total Calm3 mRNA in E17.5 or adult rat cortex and 0, 2, 4, and 6–7 DIV rat cortical neurons; n = 3,
average + SEM, t-test; *P < 0.05, **P < 0.01, ***P < 0.001.
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silencing on the observed dendritic localization of endogenous
Calm3L in rat hippocampal neurons (DIV12). The dendritic localiza-
tion of Calm3L mRNA increased upon NMDA treatment (Fig 2A and
C), and it decreased drastically upon neuronal silencing (Fig 2B and
D) (see Materials and Methods). Importantly, these treatments did
not affect total Calm3L mRNA levels as fluorescence in situ
hybridization (FISH) signal intensity in the cell body (Fig 2E and F)
and qPCR values (Fig EV2D) were not modified. Next, we investi-
gated in detail the role of the 30-UTR intron in the dendritic localiza-
tion of Calm3 transcripts. As the endogenous short isoform of
Calm3 (Calm3M; lacking the retained exon) cannot be identified
specifically due to overlapping sequences with the Calm3L, we took
advantage of a GFP mRNA reporter assay. We generated several
GFP reporters, which contained different Calm3 30-UTRs (scheme
in Fig EV2E). We analyzed the localization of the GFP reporters in
rat hippocampal neurons upon NMDA stimulation or synaptic
silencing by FISH against the GFP sequence. The dendritic localiza-
tion of GFP transcripts containing the intron (Calm3L and
Calm3INT) increased upon neuronal stimulation (Figs 2G and I, and
EV2A) and was dramatically reduced upon synaptic silencing
(Figs 2H and J, and EV2B). These data showed that the Calm3
intron in the 30-UTR is sufficient to confer activity-dependent
changes in GFP mRNA localization. Moreover, neither of these
pharmacological treatments altered the total GFP mRNA levels in
Calm3L and Calm3INT reporters (Fig EV2C). Together, these experi-
ments showed that neuronal activity regulated dendritic localiza-
tion of Calm3L mRNA via the 3
0-UTR intron without altering its
total levels.
Staufen2-mediated dendritic localization of Calm3 mRNA via its
30-UTR intron
To investigate whether Stau2 directly mediates dendritic localization
of intron-containing transcripts, we evaluated the subcellular
localization of the different GFP mRNA reporters when they were
co-expressed with the exogenous 62-kDa isoform of Stau2 (TagRFP-
Stau262). TagRFP-Stau262 expression significantly increased the
dendritic localization of the intron-containing reporter mRNAs
(Figs 3A and B, and EV3A and B). The presence of the intron in the
reporter constructs (Calm3L and Calm3INT) was confirmed by qPCR
(Fig 3H). Importantly, exogenous TagRFP-Stau262 expression did
not alter the mRNA levels of either Calm3L and Calm3INT GFP or
luciferase reporter constructs (Fig EV3C and D) or endogenous
Calm3L mRNA (Fig 3F and G). This highlighted the dependence of
Calm3 mRNA on the cis-element (i.e., the Calm3 intron) and the
trans-factor (i.e., Stau2) for its localization. Moreover, the
◀ Figure 2. Neuronal activity regulates dendritic localization of Calm3 intron-containing endogenous and GFP reporter RNAs.A, B Representative Calm3 intron FISH images of primary rat hippocampal neurons (DIV12) that were either stimulated by NMDA (15 min) (A) or silenced O/N (B) using
a standard cocktail containing TTX, CNQX, and AP5 (see Materials and Methods). Mock-treated neurons serve as the respective controls. Dendrites are visualized
with anti-MAP2 staining (green) and nuclei with DAPI (blue). Insets below show 40-lm dendritic sections marked by white boxes. Scale bar, 20 lm.
C, D Quantification of dendritic localization experiments shown in panels (A) and (B), respectively. Bars represent the mean number of spots per 40-lm dendritic
section normalized to control + SEM taken from three independent experiments. Selected dendritic regions were at least 2 cell body diameters away from the
soma. n ≥ 30 dendrites per condition; *P < 0.05; **P < 0.01; unpaired Mann–Whitney U-test.
E, F Quantification of fluorescence intensity in the cell body for Calm3L mRNA (detected by Calm3 intron FISH) upon neuronal stimulation by NMDA (15 min) (E) or
silencing O/N (F) of three different experiments as shown in panels (A) and (B), respectively. Values are normalized to respective controls; n = 3; mean number of
spots per 40-μm dendritic section normalized to control + SEM, t-test, P > 0.05, n.s. = not significant.
G, H Representative images of primary rat hippocampal neurons (DIV11) expressing TagRFP (purple) together with either GFP-Calm3L (upper rows) or GFP-Calm3M
(lower rows) that were stimulated by NMDA (15 min) (G) or silenced O/N (H) using a standard cocktail containing TTX, CNQX, and AP5 (the same as in panels A and
B; see Materials and Methods). Bright-field images are also included. Mock-treated neurons serve as the respective controls. GFP mRNA is detected using a GFP
FISH probe. Insets below each image show 40-lm dendritic sections marked by white boxes. Scale bar, 20 lm.
I, J Quantification of dendritic localization in panels (G) and (H). Bars represent the mean number of spots per 40-lm dendritic section normalized to control + SEM
taken from three independent experiments. Selected dendritic regions were at least 2 cell body diameters away from the soma. n ≥ 30 dendrites per condition;
***P < 0.001; unpaired Mann–Whitney U-test.
▸Figure 3. Stau2 overexpression increases the dendritic localization of Calm3 intron-containing GFP reporter mRNA.A Representative images of primary rat hippocampal neurons (DIV12) co-expressing either GFP-Calm3L (upper rows) or GFP-Calm3M (lower rows) together with either
TagRFP (left) or TagRFP-Stau262 (both in purple) (right). GFP mRNA is detected using a GFP FISH probe (green). Bright-field images are also shown. Arrowheads in
the top right panel indicate co-localization. Insets below each image show 40-lm dendritic sections marked by white boxes. Scale bar, 20 lm.
B Quantification of dendritic localization of the different GFP reporters identified by GFP FISH upon co-transfection together with either TagRFP or TagRFP-Stau262
as shown in (A). Bars represent the mean number of spots per 40-lm dendritic section normalized to control + SEM taken from three independent experiments.
n ≥ 30 dendrites per condition. **P < 0.01, ***P < 0.001, unpaired Mann–Whitney U-test.
C, D Representative images of neurons co-transfected with the GFP-Calm3INT reporter (mRNA identified by GFP FISH) together with either the RBP TagRFP-Stau2
62 (C) or
the unrelated RBP TagRFP-Pum2 (D). Bright-field images are also shown. Insets below each image show 100-lm dendritic sections marked by white boxes in the
main image. Arrowheads indicate dendritic co-clusters. Scale bar, 20 lm.
E Quantification of the percentage of co-localization of GFP-Calm3INT total GFP mRNA spots together with TagRFP-Stau2 or TagRFP-Pum2 within a 100-lm dendritic
section as shown in panels (C) and (D); mean + SEM, taken from three independent experiments. n ≥ 40 dendrites per condition. Selected dendritic regions were at
least 2 cell body diameters away from the soma. ***P < 0.001; unpaired Mann–Whitney U-test.
F, G Relative mRNA levels of endogenous Calm3 transcripts (total and intron-retained isoform) upon exogenous TagRFP/TagRFP-Stau2 expression nucleofected rat
cortical neurons DIV1 (F). The total Stau2 mRNA levels in these cells are also shown (G); n = 3. Bars represent mRNA levels mean + SEM normalized to control PP1a
mRNA levels; t-test; *P < 0.05.
H Relative mRNA levels of intron-retained GFP-Calm3L and GFP-Calm3INT transcripts to total GFP mRNA; graph represents mean  SEM values normalized to
respective controls, n = 3, t-test; P > 0.05.
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GFP-Calm3INT transcripts co-localized with TagRFP-Stau2
62 as well
(Fig 3C and E). This co-localization was specific for the trans-factor
Stau2 since GFP-Calm3INT transcripts did not co-localize with
another RBP such as TagRFP-Pum2 (Fig 3D and E; Calm3 mRNA
does not harbor any consensus sites for Pum2 binding). Control
experiments showed that Pum2 does not alter either the Calm3L or
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Calm3INT reporter expression in luciferase expression assays (data
not shown).
Endogenous Stau2 regulates dendritic localization of
Calm3L mRNA
Staufen forms RNPs that mediate localization of its target mRNAs in
the Drosophila oocyte [19,20]. The mammalian homolog Stau2 has
been implicated in dendritic mRNA localization [6,8]; however, a
precise mechanism and its specificity remains elusive. In order to
investigate whether mammalian Stau2 directly regulates the
dendritic localization of endogenous Calm3L mRNA, we performed
FISH in neurons in culture. Here, we observed that downregulation
of Stau2 using transiently transfected shRNA (shStau2) [21] in rat
hippocampal neurons led to substantial reduction of dendritically
localized intron-retaining Calm3L transcripts (Fig 4A and C), while
a control shRNA (shControl) did not (Fig EV4A). Importantly, the
reduction in dendritic localization of Calm3L mRNA was completely
rescued when an RNAi-resistant Stau2 (Stau2R) [6] was co-
expressed together with shStau2 (Fig 4B and C). Co-expression of
Stau2R together with an shControl plasmid did not further increase
the dendritic localization of Calm3L mRNA significantly (Fig EV4B).
Interestingly, the localization of the Calm3L isoform was mainly
restricted to the nucleus in the absence of Stau2 (Fig 4A, inset) and
this effect could also be rescued by co-expression of Stau2R (Fig 4B,
inset). Importantly, the total levels of the Calm3L mRNA isoform
did not change upon Stau2 downregulation in hippocampal (Fig 4D)
or cortical neurons (Fig 4E and F). Stau2 can shuttle between the
nucleus and the cytoplasm [22]. The nuclear restriction of the
Calm3L mRNA in the absence of Stau2 further suggests a role for
Stau2 in the nucleus. Whether this is linked to its role in dendrites
needs further investigation.
In summary, these experiments showed that mammalian Stau2
regulates the dendritic localization of the intron-containing Calm3L
isoform in primary neurons without affecting its stability.
Together, our study has several implications. Genome-wide
expression of mRNA with longer 30-UTRs increases during develop-
ment in brain and muscle [23], and such isoforms have an increased
probability of localizing to neural projections of hippocampal
neurons [24]. This is in line with our findings that the long isoform
of Calm3 containing the retained intron in its 30-UTR is preferentially
expressed in mature hippocampal neurons. Furthermore, it is this 30-
UTR intron that enables Stau2 binding and mediates its dendritic
localization. Since this dendritic Calm3L mRNA localization is regu-
lated by NMDA receptor activation, it is tempting to speculate that
Calm3L recruitment enables local protein synthesis at synapses.
Importantly, Stau2 recruitment to the retained intron in the Calm3L
mRNA suggests that Stau2 recognizes RNA structure as an element
mediating specificity. While such specific recruitment is clear for
RBPs that bind in an mRNA sequence-dependent manner (in line
with our “RNA signature” hypothesis [2]), there has been limited
evidence for dsRBPs, like Stau2. In addition, the regulation of
dendritic mRNA localization of Calm3L, without changes in mRNA
stability or decay, indicates that Stau2 performs distinct functions on
specific targets. Importantly, the binding of Stau2 to 30-UTR introns
in other 27 mRNA targets ensues an elegant mechanism wherein
Stau2 recruitment can be achieved by selective intron retention. This
would then render its function regulatable in specific cell types or
during developmental stages. This mechanism of intron retention
would be of general importance not just for Stau2 but also in the
case of other RBPs.
Materials and Methods
Immunoprecipitations and RNA isolation
Stau2 RNP isolation and immunoprecipitation (IP) were performed
in triplicate as described [10,25]. Pre-immune serum was used to
perform control IPs. Total RNA was isolated using mirVanaTM
miRNA isolation kit according to the manufacturer’s instructions
(Applied Biosystems). RNA was eluted, ethanol-precipitated, and
resuspended in nuclease-free H2O and RNA concentration measured
using a NanoDrop spectrophotometer (Thermo Scientific). For quan-
tification of mRNA levels in nucleofected rat cortical neurons, we
used the QIAshredder and RNeasy kit (Qiagen) for RNA isolation.
On-column DNase (Qiagen) treatment was performed before
proceeding to cDNA synthesis. All steps were performed according
to the manufacturer’s instructions. For Northern blot analysis, total
RNA was isolated from DIV11 rat cortical neurons (RCN). For quan-
tification of endogenous Stau2 and Calm3 (Calm3L and Calm3
all isoforms) mRNA levels from 0/2/4/6–7 DIV RCN or from
◀ Figure 4. Dendritic localization of endogenous intron-containing Calm3L mRNA is regulated by Stau2 expression levels.A Representative image of cellular localization of endogenous Calm3L mRNA (identified by intron FISH) in a rat hippocampal neuron transfected with an shRNA to
downregulate Stau2 (shStau2; green). Asterisks indicate Stau2 downregulated neurons (Stau2 levels were assessed by anti-Stau2 antibody staining; purple). Bright
field is also shown. Magnified inset (soma) shows a relative increase in nuclear localization. Magnified box on the right shows a decreased number of dendritic
Calm3L puncta in a 40-lm dendritic section marked with a white box and the corresponding phase image. The white perforated line marks the position of the
nucleus. Scale bar, 20 lm.
B Representative image of cellular localization of endogenous Calm3L mRNA (identified by intron FISH) in a rat hippocampal neuron co-transfected with an shRNA to
downregulate Stau2 (shStau2; green) and an RNAi-resistant Stau2 rescue construct (Stau2R). Selected dendritic regions were at least 2 cell body diameters away
from the soma. Magnified box on the right shows the dendritic Calm3L puncta in a 40-lm dendritic section marked with a white box and the corresponding phase
image. Panel on the lower left shows Stau2 immunostaining (purple), and panel on the upper left displays the corresponding bright field. Magnified inset (top right
corner) shows the soma. The white perforated line marks the position of the nucleus. Asterisk denotes the soma of the neuron under study. Scale bar, 20 lm.
C Quantification of dendritic Calm3L mRNA localization (identified by intron FISH) in the dendrites of neurons as in the experiments shown in (A) and (B). Bars
represent the mean number of spots per 40-lm-long dendritic region normalized to control + SEM taken from three independent experiments. n ≥ 30 dendrites
per condition, ***P < 0.001; unpaired Mann–Whitney U-test.
D Quantification of fluorescent intensity signal in the cell body to measure total levels of Calm3L mRNA [detected by Calm3 intron FISH experiments as represented in
panel (A) and (B)]. Bars represent mean values + SEM, normalized to respective controls, n = 3 experiments; t-test; P > 0.05.
E, F qPCR to measure endogenous levels of Calm3 (E) or Stau2 (F) in rat cortical neurons, where Stau2 was downregulated using an shRNA. n = 3 experiments,
mean + SEM, t-test, *P < 0.05.
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E17.5/adult rat cortex, the total RNA was obtained using TRIZOL
reagent (Thermo Scientific, 15596018) according to the
manufacturer’s instructions.
cDNA synthesis and quantitative RT–PCR
cDNA was synthesized from 0.5 to 1 lg DNase-treated RNA
using random primers and Superscript IIITM reverse transcriptase
(Invitrogen) according to the manufacturer’s instructions. For IPs,
0.5 lg of input RNA, 0.5 lg of IP RNA, and an equal volume of
pre-immune IP RNA were used as template. To detect Calm1,
Calm2, and Calm3 mRNAs, quantitative reverse transcriptase PCR
(qRT–PCR) was performed using the SYBR Green Master Mix (Bio-
Rad) according to the manufacturer’s instructions. Primers were
optimized to achieve 95–105% efficiency; qRT–PCR data were
analyzed using the comparative DDCT method [26]. For cDNA
synthesis using total RNA isolated from rat cortical neurons, 2 lg
total RNA for each sample was treated with 1 unit of DNase I
(Thermo Fisher Scientific) at 37°C for 30 min. DNase-treated RNA
was split in two: 1 lg was used for cDNA synthesis and the rest
1 lg for minus reverse transcriptase (RT) reactions. Superscript
III (#18080093; Thermo Fisher Scientific) was used to perform
cDNA synthesis according to the manufacturer’s instructions. For
detecting mRNA levels by qPCR, a homemade SYBR Green Mix
[containing the following components at a final concentration of
1 M betaine (B0300; Sigma), 1× standard Taq buffer (NEB), 16 lM
dNTPs (N0447S; NEB), BSA 20 lg/ml (B9000S; NEB), 0.6 U per
reaction Hot-Start Taq DNA polymerase (M0495S; NEB), and
1 ll/ml of 1:100 SYBR Green (20010; Lumiprobe)] (in ddH2O) was
used. Forward and reverse primer pair mix was used 2 ll per
reaction from the following stock concentrations: Renilla and fire-
fly luciferase at 3 lM, GFP 5 lM, and Calm3 ORF Fwd/Rev
2.5 lM; Calm3 ORF Fwd/Calm3 intron Rev 4 lM, Stau2 5 lM,
pp1a 3 lM, GFP Fwd/Calm3 intron Rev 4 lM, and Renilla luci-
ferase Fwd/Calm3 intron Rev 4 lM. Five microliters of a 1:10 dilu-
tion of cDNA was added to total 15 ll reaction, in duplicate for
each primer set. –RT and ddH2O controls were used for each
sample. qPCRs were performed in a LightCycler 96 system (Roche)
and analyzed using the comparative DDCT method [27]. PP1a
mRNA levels were used as internal control for normalization.
Primer sets were rigorously validated on dilution series and opti-
mized to achieve 95–105% efficiency before use.
Stau2 iCLIP and analysis
We performed Stau2 iCLIP from E18 (embryonic day 18) mouse
brain samples using anti-Stau2 antibodies [25] or the pre-immune
serum (PIS) as a control according to a protocol described previ-
ously [14] with the following modifications. At the RNase diges-
tion step, 20 U of RNase I (Thermo Fisher Scientific, #AM2295)
was added to 1 ml of brain lysate. At the IP step, 450 ll of lysate
was incubated with 2 lg of anti-Stau2 antibody for 2 h at 4°C,
followed by incubation for 1 h at 4°C on a rotation wheel with
100 ll of protein G beads (Dynabeads, Thermo Fisher Scientific,
#10004D). Upon SDS–PAGE and transfer to nitrocellulose, the
region corresponding to the molecular weight larger than Stau2
(> 60 kDa) was excised and RNA was extracted from the
membrane.
High-throughput sequencing was done using 50 cycles on Illu-
mina GAII. The sequence reads were processed using the iCount
server (http://icount.biolab.si) as described before [14]. Briefly,
sequence reads are mapped to the mouse genome (mm9/NCBI37)
using Bowtie software [28] with the following parameters
(-v 2 -m1 -a –best –strata) and the mapped reads were collapsed
referring the unique molecular identifiers included in the reverse
transcription primer. The genomic regions were annotated using
Ensembl annotation (V.59). The significant crosslinking clusters
(flanking region of 15 nt and FDR < 0.05) were identified by
comparing them with randomized control [13,14,29]. The rando-
mers were registered and the barcodes were removed before
mapping the sequences to the genome sequence allowing two
mismatches using Bowtie version 0.12.7 (command line: -v 2 -m
1 -a –best –strata). The nucleotide preceding the iCLIP cDNAs
mapped by Bowtie was used to define the crosslink sites
identified by truncated cDNAs. The method for the randomer
evaluation, annotation of genomic segments, and identification of
significantly clustered crosslinking events was performed with
FDR 0.05 and a maximum spacing of 15 nt, as described earlier
[13], such that the positions of crosslink sites were randomized
within individual RNA regions (i.e., introns, CDS, and UTRs sepa-
rately). The replicate iCLIP experiments for the same protein were
grouped before performing the analyses. We used Gencode anno-
tation to define the RNA regions and identify 30-UTRs containing
retained introns.
Calm3 mRNA 30-UTR secondary structure prediction
The minimum free energy secondary structure of mouse Calm3
mRNA long 30-UTR (TROMER Transcriptome database id:
MTR004019.7.453.0) was predicted using the RNAfold program with
the default parameters [30].
Primary neuron cultures, transfections, and
pharmacological treatments
Embryonic day 17 (E17) hippocampal neurons were isolated
from embryos of timed pregnant Sprague Dawley rats (Charles
River) as described [6] and transfected using a calcium phos-
phate protocol [31,32]. For NMDA-mediated neuronal stimula-
tion, after 24 h of expression of transfected plasmids,
hippocampal neurons were treated for 10 s with 100 lM NMDA
in Ca2+/Mg2+-free PBS and then incubated in B27-NMEM
medium containing 100 lM NMDA for 15 min. Cells were then
rinsed with HBSS and fixed. For neuronal silencing, after 6 h of
expression of plasmids, cells were washed once with HBSS and
then incubated overnight at 37°C in NMEM-B27 medium contain-
ing 100 lM 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX), 50 lM
2-amino-5-phosphonopentanoic acid (AP5), and 1 lM
tetrodotoxin (TTX). Cells were then washed twice with HBSS
and fixed. Mock-treated cells were used as controls for both
treatments. Where indicated, dissociated primary cortical neurons
were prepared from rat cortices remaining from hippocampal
dissections [10]. Rat primary cortical neurons (E17) were
transfected using Amaxa Nucleofection (Rat Neuron Nucleofector
Kit, Lonza, program O-003 according to the manufacturer’s
instructions).
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Imaging-based GFP expression assay in primary neurons
Gene fragments of interest were cloned downstream of the GFP
gene into the pEGFP vector under the control of a shorter version
of the synapsin promoter. As control, empty GFP reporter plas-
mid was used. DIV11 primary rat hippocampal neurons were co-
transfected with 1.5 lg of reporter plasmid and 1.5 lg of TagRFP
or TagRFP-Stau2 or TagRFP-Pum2 plasmid using calcium phos-
phate and fixed at DIV12 for performing FISH as described
below.
FISH and immunocytochemistry
Fluorescence in situ hybridization using tyramide signal amplifi-
cation was performed as described [33,34]. The following RNA
probes were used: Calm3 intron and GFP sense and antisense
from a cloned pBluescript II KS+ construct described below.
Immunocytochemistry was performed as previously described
[34]. For FISH following Stau2 knockdown, DIV11 primary
hippocampal neurons were transfected (co-transfection of
control/Stau2 shRNA with either TagRFP or RNAi-resistant
TagRFP-Stau2 62-kDa isoform) using calcium phosphate and
fixed at DIV16. For GFP mRNA FISH, DIV11 primary hippocampal
neurons were transfected [co-transfection of GFP constructs
containing different Calm3 30-UTRs with either TagRFP or
TagRFP-Stau2 (i.e., the 62-kDa isoform)] using calcium phos-
phate and fixed at DIV12.
Imaging and statistical data analysis
Images were acquired in Zen acquisition software using an
Observer Z1 microscope (both from Zeiss) with a 63× planApo oil
immersion objective (1.40 NA) and a CoolSnap HQ2 camera
(Olympus). For FISH experiments, z-stacks of neurons were
acquired (50 stacks with optimal step size suggested by the Zen
acquisition software ~0.26 nm). Images were then deconvoluted
using the Zen deconvolution module. For quantification, imaging
and selection of 40-lm dendritic regions for each image was done.
Images were then projected orthogonally. The Analyze particles
plugin in the ImageJ software was used for quantifying the number
of spots per 40-lm dendritic region that was at least 2 cell body
diameters away from the soma. For cell body intensity quan-
tification from FISH images, the measure function in the ImageJ
software was used. The average intensity/lm2 of each soma was
quantified.
For quantifying co-localizing events between GFP-Calm3INT
and TagRFP-Stau262, a deconvoluted set of images were selected
and manually scored by two independent observers. Percentage
of total GFP-Calm3INT particles (in a 100-lm dendritic region) co-
localizing with TagRFP-Stau262 were quantified. We used
TagRFP-Pum2 as control in parallel. For quantifying co-localizing
events, a deconvoluted set of z-stacks was selected and manually
scored blind to the experimental conditions (without knowing
whether it was TagRFP-Stau2 or TagRFP-Pum2) by two indepen-
dent observers. Only the spots that were in the same plane and
had their center of focus co-localizing were scored as co-localiza-
tion events. Individual “blind” scores were then averaged, and
the data were presented as percentage of total particles
co-localizing in a 40-lm dendrite (2 cell body diameters away
from the soma).
For all experiments, ≥ 30 dendrites (1 dendrite per neuron)/
≥ 30 cell body per set from three independent experiments were
selected for quantification. The conditions of experiments were kept
blind for the observer until final analysis. GraphPad Prism 7.0 soft-
ware was used to test the normal distribution of the data
(D’Agostino–Pearson omnibus test) and for significance testing
before decision of the statistical test to be used. Normalized values
were used to determine significant differences with the unpaired
Mann–Whitney U-test for samples with unequal variances. All
graphs were plotted in MS Excel.
Antibodies
Primary antibodies: Mouse monoclonal and rabbit polyclonal anti-
Stau2 antibodies (both used at 1:500 dilution) [35] were generated
by affinity purification from existing immune sera; polyclonal anti-
GFP antibodies were a gift from Werner Sieghart (CBR, Vienna,
Austria) (used at 1:5,000 dilution). The following commercial
antibodies were used: rabbit polyclonal anti-RFP (1:4,000) (Life
Technologies, R10367); and monoclonal anti-MAP2 (1:500) (Sigma-
Aldrich, M4403).
Secondary antibodies: Donkey anti-mouse A488-, A555-, or
A647-conjugated antibodies and donkey anti-rabbit A555- or A647-
conjugated antibodies (all from Life Technologies) were used at
1:1,000 dilution.
Plasmids
shControl (Dharmacon) and shStau2 [21] sequences were cloned
into the pSuperior + GFP vector system as described. Full-length
Calm3 30-UTR was PCR-amplified from a rat EST plasmid obtained
from ImaGenes (IMAGp998L0619945Q) (accession number
AF231407), using the primers Calm3L Fwd and Rev, and then
cloned into the psiCHECK2 vector (Promega) as described [10].
For cloning the Calm3 intron, the primers Calm3INT Fwd and Rev
were used, and it was cloned into pEGFP-C2 vector via EcoRI/
BamHI and then further sub-cloned into pBluescript KS+ vector
via SacI/BamHI (for FISH probes) and into psiCHECK2 (Promega)
dual-luciferase reporter plasmid via SacI/SalI for qPCR on luci-
ferase reporters.
Intermediate Calm3 30-UTR (Calm3M) was PCR-amplified from
a rat EST plasmid obtained from ImaGenes (IRBQp994H052D)
(accession number AF231407), using the primers Calm3M Fwd
and Rev, and then cloned into psiCHECK2 plasmid via SalI/NotI.
The CMV promoter in pEGFP-C1 plasmid was replaced by
synapsin (Syn) short promoter using the following primers: Syn
Fwd and Rev. This construct was then used to generate GFP
constructs with Calm3 full-length 30-UTR (GFP-Calm3L) via
HindIII/SalI, Calm3 intermediate 30-UTR (GFP-Calm3M) via
HindIII/SalI, and Calm3 intron (Calm3INT) via EcoRI/BamHI.
The coding sequence for 62-kDa isoform of Stau2 was cloned
into pTagRFP vector using the following primers: Stau2 Fwd and
Rev via XhoI/SacI. The RNAi-resistant Stau2 (Stau2R) (in
pEGFP-N1) generated previously [6] was sub-cloned into
pTagRFP-C. See the “Primers and shRNA sequences” section
below.
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Northern blot
10–15 lg of total RNA from cortical neurons DIV11 was electro-
phoresed in agarose–formaldehyde gels (1%), transferred to
Nytran membranes (Hybond-N, Amersham), hybridized following
standard procedures [36], and analyzed using PhosphorImager
screens in a Typhoon FLA9500 multi-mode imaging scanner and Fiji
software. Fragments of open-reading frames (ORF) and 30-UTR
intron were obtained by PCR and cloned into pBluescript KS+ plas-
mid (see primer sequences below). Double-stranded DNA was
obtained afterward by restriction endonuclease digestion and
radiolabelled using the random primer PrimeIt kit (Stratagene) and
[a-32P]dCTP.
Luciferase reporter mRNA expression and RNA isolation
Gene fragments of interest were cloned downstream of the
Renilla luciferase (Luc) gene into the psiCHECK2 vector
(Promega). As control, empty Luc reporter plasmid was used.
HeLa cells (plated in 24-well plates with 100,000 cells per well)
were transfected with 0.1 lg of reporter plasmid and 0.4 lg of
TagRFP or TagRFP-Stau2 plasmid (per well) using Lipofectamine
Primers and shRNA sequences
Primer name Species Primer sequence (50–30)
(qPCR) Calm1 Rattus norvegicus Fwd: TTCCCCCTCTAGAAGAATCAAA
Rev: CCACCAACCAATACATGCAG
(qPCR) Calm2 Rattus norvegicus Fwd: AAGGTTCCCCCACTGTCAGA
Rev: AAGCCACATGCAACATGGTA
(qPCR) Calm3 Rattus norvegicus Fwd: ACAGCGAGGAGGAGATACGA
Rev: CATAATTGACCTGGCCGTCT
(qPCR) Firefly luciferase Photinus pyralis Fwd: GAGTCTATCCTGCTGCAGCAC
Rev: CTCGTCCACGAACACCACTC
(qPCR) Renilla luciferase Renilla reniformis Fwd: GTCCGGCAAGAGCGGGAATGG
Rev: ACGTCCACGACACTCTCAGCAT
(qPCR) Calm3L Rattus norvegicus Calm3 ORF Fwd: GGAGACGGCCAGGTCAATTATGC
Calm3 intron Rev: GTCACCCAAAAGAAGGGCAAACC
(qPCR) Pp1a Rattus norvegicus Fwd: GTCAACCCCACCGTGTTCTTG
Rev: CTGCTGTCTTTGGAACTTTG
(qPCR) Stau2 Rattus norvegicus Fwd: GAACATCTCCTGCTGCTGAAG
Rev: ATCCTTGCTAAATATTCCAGTTGT
(qPCR) GFP Aequorea victoria Fwd: ACCCAGTCCGCCCTGAGCAA
Rev: GCGGCGGTCACGAACTCCAG
(Cloning) Calm3L Rattus norvegicus Fwd: AGGCCCGGGCAGCT
Rev: GGTAGTCACTGTATTTTATTGGAAAACA
(Cloning) Calm3INT Rattus norvegicus Fwd: GAATTCGGGAGCCTCTGC
Rev: CTGGGCAGGTCCCAGGGATCC
(Cloning) Calm3M Rattus norvegicus Fwd: ACTTCAGTCGACAGGCCCGGGCAGCTGGC
Rev: CTGGTTGCGGCCGCGGTAGTCACTGTATTTTATTGGAAAAC
(Cloning) Stau262 Rattus norvegicus Fwd: ATGGCAAACCCCAAAGAGAA
Rev: CTAGATGGCCGACTTTGATTTC
(Cloning) Syn Rattus norvegicus Fwd: ATACCCTGTGTCATTCCTTGTT
Rev: GGTGGCAGCTTGGGGCA
Calm3 ORF (Northern blot) Rattus norvegicus Fwd: CATGGCTGACCAGCTGACC
Rev: CACTTCGCAGTCATCATCTGTAC
Calm3 30-UTR intron (Northern blot) Rattus norvegicus Fwd: GGTCTCACTGACGCTGTTCT
Rev: GGCAGAAAGCGATGCCAAGT
shStau2 Rattus norvegicus GATATGAACCAACCTTCAA
shControl Rattus norvegicus GATCCCCCTCCAAAGTTCGATGGTTTTCAAGAGAAACCATCGAACTTTGGAG
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2000 (Invitrogen). Total RNA was isolated 24 h after transfection.
For quantification of luciferase mRNA levels in Lipofectamine-
transfected HeLa cells, we used the QIAshredder and RNeasy kit
(Qiagen) for RNA isolation. On-column DNase (Qiagen) treatment
was performed before proceeding to cDNA synthesis. All
steps were performed according to the manufacturer’s instruc-
tions.
Data availability section
Primary data
Stau2-iCLIP data were submitted to ArrayExpress. It can be accessed
through the following link: http://www.ebi.ac.uk/arrayexpress/e
xperiments/E-MTAB-5703.
Referenced data
iCLIP data for the RBPs TDP-43 and FUS from E18 mouse brains are
published [14]. The Stau2 IP data from E17 rat brains are published
as well [10].
Expanded View for this article is available online.
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Expanded View Figures
◀ Figure EV1. Stau2 binds to the intron-containing Calm3 mRNA isoform and regulates its expression (related to Fig 1).
A Snapshots from UCSC genome browser visualization of transcripts on mm10 version of mouse genome that have retained introns annotated within 3’-UTRs, as
defined by UCSC genes or ENCODE. The number of cDNAs that identify each crosslink position is shown in the track “STAU2 crosslinks”. The maximum cDNA number
is shown at the left of each track. Crosslinks in RNAs on the plus strand are shown in blue, and the cDNA count value is positive. In genes on the minus strand,
crosslinks are shown in orange, and cDNA count value is negative.
B Northern hybridizations using radiolabeled double-stranded DNA probes as indicated in scheme; Calm3 ORF in green and intron in blue (left panel). Ribosomal RNAs
(rRNAs) were visualized by ethidium bromide staining (right panel). The arrows indicate the position of the long and the spliced isoform of Calm3 mRNA detected
with probe Calm3 ORF.
C qPCR experiments to measure the percentage of Calm3L mRNA isoform in total Calm3 mRNA levels in E17.5 or adult rat cortex and 0, 2, 4, and 6–7 DIV rat cortical
neurons; n = 3.
D Representative images of endogenous Calm3 intron FISH (red) to visualize the levels of Calm3L mRNA in different stages of in vitro development of rat hippocampal
neurons (1, 4, 8, 12, and 15 DIV). Nuclei (DAPI; blue) and anti-MAP2 immunostaining (green) are also included. Scale bar: 20 lm.
▸
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EV2
◀ Figure EV2. Dendritic localization of Calm3 intron-containing GFP reporter RNAs increases with neuronal stimulation and is reduced by silencing of neurons(related to Fig 2).
A, B Representative images of primary rat hippocampal neurons (DIV11) expressing TagRFP (purple) together with either GFP-Calm3INT (upper row) or GFP (lower row)
that were stimulated by NMDA (A) or silenced (B) using a standard cocktail containing TTX, CNQX, and AP5 (see Materials and Methods). Bright-field images are
also included. Mock-treated neurons serve as appropriate controls for (A) and (B). These data compliment the datasets shown in Fig 2A and B. GFP mRNA is
detected using a GFP FISH probe. Scale bar, 20 lm.
C Quantification of fluorescence intensity in the cell body to measure total levels of GFP reporter mRNA (detected by GFP FISH experiments as represented in Figs 2G
and H, and EV2A and B) using the indicated Calm3 30-UTR constructs with indicated pharmacological treatment; bars represent mean  SEM values normalized to
respective controls, n = 3, t-test; P > 0.05.
D qPCR to detect the effect of neuronal activation/silencing on total levels of endogenous Calm3L or all Calm3 isoforms in rat cortical neurons DIV7; n = 3. Bars
represent mean + SEM values of mRNA levels normalized to PP1a, t-test; P > 0.05.
E Scheme representing the GFP reporter constructs used in this study.
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Figure EV3. Stau2 overexpression increases the dendritic localization of Calm3 intron-containing GFP reporter mRNA (related to Fig 3).
A, B Representative images of primary rat hippocampal neurons (DIV11), expressing either GFP-Calm3INT (A) or GFP (B) with co-expression of either TagRFP (left) or
TagRFP-Stau262 (right) (both in purple). GFP mRNA is detected using a GFP FISH probe (in green); bright-field images are also shown. These data compliment the
datasets shown in Fig 3A and B. Scale bars, 20 lm.
C Quantification of fluorescence intensity in the cell body to measure total levels of GFP reporter mRNA (detected by GFP FISH experiments represented in Figs 3A
and EV3A and B) using the indicated Calm3 30-UTR constructs with co-expression of either TagRFP or TagRFP-Stau262; bars represent mean values  SEM
normalized to respective controls, n = 3, t-test; P > 0.05, n.s. = not significant.
D Quantification of Renilla (RL) vs firefly (FL) luciferase mRNA in HeLa cells using the indicated Calm3 30-UTR constructs with co-expression of either TagRFP or
TagRFP-Stau262; bars represent mean values + SEM normalized to respective controls, n = 3, t-test; P > 0.05.
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Figure EV4. Stau2 downregulation substantially decreases dendritic localization of endogenous intron-containing Calm3L mRNA (related to Fig 4).
A, B Representative images of endogenous Calm3L mRNA visualized by a FISH probe directed against the intron (Calm3 intron FISH) in primary rat hippocampal
neurons expressing a control shRNA with co-expression of either TagRFP (A) or a (TagRFP-tagged) RNAi-resistant Stau2R (B). Asterisks indicate shRNA-expressing
neurons. The white perforated line marks the position of the nucleus. Magnified insets on the upper left show cytoplasmic localization of Calm3L mRNA. Magnified
boxes on the right show dendritic Calm3L puncta and the corresponding phase image. Selected dendritic regions were at least 2 cell body diameters away from the
soma. Panels on the lower left show Stau2 immunostaining and panels on the upper left the corresponding phase contrast. Scale bar, 20 lm. These data
compliment the datasets represented in Fig 4A–C.
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credited.SUMMARY
RNA-binding proteins play crucial roles in directing
RNA translation to neuronal synapses. Staufen2
(Stau2) has been implicated in both dendritic RNA
localization and synaptic plasticity in mammalian
neurons. Here, we report the identification of func-
tionally relevant Stau2 target mRNAs in neurons.
The majority of Stau2-copurifying mRNAs expressed
in the hippocampus are present in neuronal pro-
cesses, further implicating Stau2 in dendritic mRNA
regulation. Stau2 targets are enriched for secondary
structures similar to those identified in the 30 UTRs of
Drosophila Staufen targets. Next, we show that
Stau2 regulates steady-state levels of many neuronal
RNAs and that its targets are predominantly downre-
gulated in Stau2-deficient neurons. Detailed analysis
confirms that Stau2 stabilizes the expression of one
synaptic signaling component, the regulator of G
protein signaling 4 (Rgs4) mRNA, via its 30 UTR.
This study defines the global impact of Stau2 on
mRNAs in neurons, revealing a role in stabilization
of the levels of synaptic targets.
INTRODUCTION
In neurons, RNA-binding proteins (RBPs) are essential for direct-
ing gene expression to distinct regions of the cell, such as growth
cones or synapses (Holt and Bullock, 2009). Local protein
synthesis in neuronal dendrites and at synapses is critically
important for both synaptic development and plasticity (Costa-
Mattioli et al., 2009; Sutton and Schuman, 2006; Kandel,
2009). Staufen proteins are double-stranded RBPs (dsRBP)Cell Reinvolved in RNA localization and synaptic plasticity (Dubnau
et al., 2003; Lebeau et al., 2011; St Johnston et al., 1991).
Work in several organisms indicates a role in RNA transport,
stability, translation, and anchoring (Dugré-Brisson et al., 2005;
Kim et al., 2005; Micklem et al., 2000; Tang et al., 2001; Zimyanin
et al., 2008). However, Staufen’s role in RNA localization in
neurons is not well understood.
Staufen2 (Stau2) is highly enriched in the brain and is impor-
tant for dendritic spine morphogenesis, which represent excit-
atory synapses (Goetze et al., 2006). It is viewed as one of the
best markers to follow the transport of RNPs due to its fast bidi-
rectional movement along dendritic microtubules (Köhrmann
et al., 1999; Zimyanin et al., 2008). Supporting its role in RNA
localization, expression of a dominant-negative Stau2 relocal-
izes a large proportion of total dendritic RNA toward the cell
body (Tang et al., 2001). Furthermore, downregulation of Stau2
in neurons impairs metabotropic glutamate receptor (mGluR)-
dependent long-term depression (LTD) (Lebeau et al., 2011).
Outstanding questions regarding the role of Stau2 in mature
neurons include which mRNAs it interacts with and whether it
plays a role in regulating their expression or localization. Here,
we sought to globally identify which mRNAs are associated
with Stau2 protein in the brain and investigate their regulation.
We report that Stau2 modulates the expression—most notably
the stabilization—of a subset of target RNAs that encode synap-
tic proteins. These targets are enriched for a recently identified
RNA secondary structure bound by Drosophila Staufen (Laver
et al., 2013). In conclusion, our data identify a mechanism for
Stau2 regulation of synaptic targets in neurons.
RESULTS
Identification of Stau2 Target RNAs from Rodent Brain
To isolate Stau2-containing RNA granules not linked to mem-
branes, we developed a protocol for RNP purification (Fritzscheports 5, 1511–1518, December 26, 2013 ª2013 The Authors 1511
Figure 1. Identification of Stau2 Target
RNAs from Soluble Stau2 RNPs
(A) The three-step biochemical procedure to
isolate endogenous Stau2 RNPs and identify their
RNA content.
(B) Heatmap of Affymetrix GeneChip arrays
showing the relative intensity of significantly en-
riched genes (adjusted p value < 0.05) in the Stau2
IP compared to the input from three independent
experiments. Each row represents a single mRNA.
(C) Validation of microarrays by qRT-PCR. mRNA
was isolated from input, Stau2 IPs, control IPs
(using rabbit preimmune sera), and the candidate
target genes quantified by qRT-PCR. Enrichment
was calculated as the IP relative to input and
cross-normalized to the reference genesKif5c and
Arntl. The mean ± SEM is shown (n R 3).
(D) Correlation of enrichment values (Stau2 IP/
input) obtained by microarray versus qRT-PCR.
Each point represents an individual mRNA, which
was quantified using both methods (n R 2).
Pearson’s correlation coefficient was significant
(p < 0.0001).
(E) Selected GO term enrichments observed for
Stau2-associated mRNAs. RNAs enriched R1.5-
fold (Stau2 IP/input) were used (n = 1,113).
See also Figure S1 and Tables S1 and S2.et al., 2013) (Figure 1A). Soluble (S20) embryonic day 17 (E17) rat
brain preparations were separated by density gradient centrifu-
gation. Western blotting was used to identify those fractions
that were enriched for Stau2 but depleted of endoplasmic retic-
ulum (ER). Fractionation before immunoprecipitation (IP) greatly
reduces nonspecific interactors, as the ER is associated with
ribosomes and translating RNAs.
Affinity-purifiedmonospecificStau2antibodiescoupled topro-
tein A beads were used to isolate endogenous RNPs from ER-
depleted brain fractions. In three independent experiments, total
RNA was isolated from the IP and analyzed by microarray. Equal
amounts of IP and input RNAwere hybridized to the array and the
identified RNAs were ranked by enrichment in the IP relative to
input (Table S1). This identified a total of 1,206 RNAs significantly
enriched in theStau2 IP (usinganaverageof >1.5-foldenrichment
as a cutoff across three IPs and an adjusted p value < 0.05;1512 Cell Reports 5, 1511–1518, December 26, 2013 ª2013 The AuthorsFigure 1B). This represents 8.5% of
mRNAs expressed in the input fractions.
The enrichment of 38 candidate RNAs
from independent IPs was confirmed by
quantitative RT-PCR (qRT-PCR) (Fig-
ure 1C; Table S2). The candidates in-
cluded RNAs with a range of enrichments
and abundance to ensure that all classes
of RNAs could be validated. Preimmune
serum coupled to protein A beads was
used as a negative control (Figure 1C).
Note that the preimmune IPs could not
be used as a control for the microarrays
because insufficient RNA was isolated.
The correlation between qRT-PCR and
microarray data for the selected 38 geneswas highly significant (Pearson’s correlation coefficient, p <
0.0001; Figure 1D), indicating that the microarray data are robust
and reliable. As an independent control, we testedwhether candi-
date RNAswere enriched in the IP of another RBP, Barentsz (Btz),
which forms distinct RNPs compared to Stau2 in neurons (Fritz-
sche et al., 2013). Only one (Sacm1l) out of the six tested Stau2
target RNAs was also enriched in the Btz IP (Figure S1A). Indeed,
no overlapping targets were enriched >2-fold in both IPs by
microarray analysis (M.A.K., M.D., J.E.H.-F., D. Karra, P.P., S.T.,
and M. B., unpublished data) further suggesting that most of the
identified Stau2 targets are specific to this RNP.
Increasing evidence demonstrates that individual RBPs can
regulate a biologically coherent set of target RNAs and coordi-
nate their expression (Hogan et al., 2008; Keene, 2007; Ule
et al., 2005). Therefore, we performed DAVID Gene Ontology
(GO) term analysis of the Stau2 targets (>1.5-fold) and identified
Figure 2. Most Stau2 Targets Localize to Neuronal Processes in the
Hippocampus CA1 Region
(A) Stau2 targets identified in this study were compared to a new data set of
process-localized mRNAs from the CA1 region of the hippocampus (Cajigas
et al., 2012). The data set was derived from RNA sequencing of the soma and
neuropil layers from the CA1 region of mouse hippocampus. The first column
indicates the number and percentage of Stau2 target RNAs expressed in the
CA1 somatic layer. The second column indicates the number and percentage
of Stau2 target mRNAs that are expressed in the CA1 that are also found in the
neuropil (77%).
(B) Localization of two Stau2 target mRNAs, Rgs4 and Calm3, was tested by
fluorescent in situ hybridization using digoxigenin-labeled riboprobes in pri-
mary hippocampal neurons (15–16 days in vitro). Sense probes were used as
negative controls. Scale bar, 10 mM.
See also Table S3.
Cell Reenriched classes of genes (Huang et al., 2009). We found a sig-
nificant enrichment of several GO term categories, including pro-
tein localization and signal transduction mediated by small
GTPases (p values of 5.43 1010 and 3.43 1010, respectively;
Figure 1E). Interestingly, eight RNAs encode proteins that are
part of a G protein-coupled receptor (GPCR) signaling pathway
(Figure S1B). This pathway is important for signaling through
synaptic receptors such as the dopamine, glutamate, and
muscarinic acetylcholine receptors, among others (Lin et al.,
2002; Miura et al., 2002; Rashid et al., 2007). This result raises
the possibility that Stau2 may regulate RNAs encoding function-
ally related proteins as described for other neuronal RBPs, such
as Nova and FMRP (Darnell et al., 2011; Ule et al., 2005). In sup-
port of a possible role of Stau2 in intracellular signaling
cascades, we found both ERK1 and ERK2 kinases to be misre-
gulated when Stau2 levels were reduced in primary cortical
neurons (Figures S1C and S1D).
The Majority of Stau2 Target mRNAs Are Localized
to Neuronal Processes
Local translation at synapses contributes to several forms of
synaptic plasticity (Costa-Mattioli et al., 2009; Sutton and Schu-
man, 2006). Recent data indicate that 2,550 mRNAs localize to
the processes of CA1 neurons in the hippocampus (Cajigas
et al., 2012). According to those data, 3,508 transcripts were ex-
pressed in these cells, therefore suggesting that 72% of all
RNAs in the CA1 processes may be locally translated. To deter-
mine the number of Stau2 target mRNAs in this local pool, we
cross-referenced our data set with that of Cajigas et al. (2012)
(Table S3). Approximately 30% of the Stau2 targets were ex-
pressed in the CA1 somatic layer (Figure 2A). Of these, 77%
were found in the neuropil layer, which consists of neuronal pro-
cesses (Figure 2A). This is a small but significant enrichment of
localized messages in the IP over input, which also consisted
of 72% localized messaged (resampling without replacement,
p = 0.012). This suggests that the majority of endogenous Stau2
target RNAs localize away from the cell body into neuronal pro-
cesses. Using fluorescence in situ hybridization (FISH), we
further confirmed the localization of two Stau2 targets of interest,
Rgs4 and Calm3, to dendrites of primary rat hippocampal
neurons (Figure 2B). Thus, Stau2 may play a role in dendritic
localization of its target mRNAs.
Stau2 Regulates mRNA Levels in Primary Neurons
To elucidate the role of Stau2 on the regulation of target mRNAs
in primary neurons, we investigated the impact of Stau2 downre-
gulation on global gene expression. Primary cortical neurons
were transduced with lentivirus vectors expressing short hairpin
RNAs (shRNAs), which target Stau2 or a control hairpin (targeting
luciferase). After 5 days, total RNA was isolated and differences
in gene expression were identified by microarray from three
independent experiments. When Stau2 levels were reduced to
10% of endogenous levels, 349 target mRNAs were downre-
gulated and 99 upregulated (Figure 3A, lane 3; Figure 3B; Table
S4). Interestingly, however, when a less potent shRNAwas used,
resulting in 30% of Stau2 remaining (shStau2-v3; Figure 3A, lane
4), the levels of only 13 RNAs changed (Figure S2A), with Stau2
itself being the only common target. These results suggest thatports 5, 1511–1518, December 26, 2013 ª2013 The Authors 1513
Figure 3. Stau2 Regulates mRNA Levels in
Primary Neurons
(A) Western blot from primary cortical neurons
transduced with lentivirus expressing two inde-
pendent shRNAs targeting Stau2 or controls (2 + 5
DIV). Four isoforms of Stau2 (62, 59, 56, and
52 kDa) are expressed. Tubulin was used as
loading control.
(B) Microarray analysis was performed on total
RNA isolated from shStau2-v2 and shControl-v2
transduced primary cortical neurons. Significantly
changedmRNAs are ordered by fold change in the
knockdown relative to the control. Each dot rep-
resents a single mRNA, with red showing down-
regulated mRNAs and green showing upregulated
mRNAs. Stau2 is indicated because it was the
most downregulated RNA.
(C) qRT-PCR validation of eight mRNAs from the
microarray. Relative levels of the indicated RNAs
were determined in the shStau2-v2 knockdown
relative to the control, shControl-v2, using cross-
normalization to the reference genes Kif5c and
PPIA. Bars represent the mean ± SEM (n = 3).
(D) Correlation between the validated targets
shown in (C) and the fold change for the same
targets according to the microarray (Pearson’s
correlation coefficient, p < 0.001).
(E and F) GO terms enrichments (p < 0.05) for
significantly downregulated (E) and upregulated
(F) mRNAs following Stau2 downregulation (KD)
in cortical neurons (shStau2-v2). Benjamini-
Hochberg (BH) adjusted p values are shown.
See also Figure S2 and Table S4.30% of normal Stau2 levels are sufficient to maintain target
mRNA levels in primary neurons. Themicroarray data were again
validated by qRT-PCR, showing a high correlation between both
data sets (Figures 3C, 3D, S2B, and S2C). Interestingly, the
downregulated RNAs were enriched for ‘‘synaptic’’ and
‘‘learning and memory’’-related GO term categories, whereas
the upregulated ones were enriched for different GO terms (Fig-
ures 3E and 3F). Together, gene expression analysis shows that
the majority of target genes identified are downregulated in
Stau2 knockdown neurons.
Identification of a Staufen-Recognized Structure in
Downregulated Stau2 Targets
In order to further investigate how Stau2 might regulate specific
transcripts in the brain, we searched for structural elements en-
riched in Stau2 targets. Here, we took advantage of our two
independentmicroarray experiments to select themost stringent
set of targets. Specifically, we selected those mRNAs that were
enriched in the IP of endogenous Stau2 RNPs from rat brain,
which were also affected by Stau2 downregulation in primary1514 Cell Reports 5, 1511–1518, December 26, 2013 ª2013 The Authorsneurons. This resulted in 32 targets
whose levels decreased in the absence
of Stau2 and 6 that increased (Figure 4A;
Table S5). Interestingly, and in line
with what was recently reported for
Drosophila Staufen targets (Laver et al.,2013), the median length of the 30 UTRs of Stau2-regulated
targets was significantly greater than that in the rat 30 UTRome
(1,189 bases for targets versus 496 bases for the rat 30 UTRome,
Wilcoxon rank sum p < 0.0001; Figure 4B). We next took advan-
tage of a novel computational strategy that was recently used to
identify structural elements in Drosophila Staufen target RNAs
(Laver et al., 2013) to assess whether the Stau2 targets were
enriched for Staufen-recognized structures (SRSs) similar to
those in Drosophila. We found that the Stau2 target 30 UTRs
were highly enriched for Type III SRSs (Wilcoxon rank sum p <
0.001; Figure 4C). Type III SRSs are defined by a stem consisting
of at least 10 out of 12 paired bases and no more than two
‘‘unpaired’’ bases (i.e., those that participate in neither canonical
nor noncanonical base pairings) (Laver et al., 2013). Notably,
95% (19 out of 20) of the analyzed downregulated targets carried
one or more Type III SRSs whereas only 33% (one out of three)
analyzed upregulated targets contained a type III SRSs (Fig-
ure S3; data not shown).
Given that downregulation was the predominant effect of
Stau2 knockdown on the target RNAs, we further validated
Figure 4. Stau2-Stabilized Target mRNA 30 UTRs Are Enriched for Staufen-Recognized Structures
(A) Overlap between mRNAs enriched in the Stau2 IP (from Figure 1) and mRNAs significantly changed following Stau2 knockdown (from Figure 3B). mRNAs
changed following the Stau2 knockdown (KD) are separated into upregulated (green circle) and downregulated (red circle).
(B) Median 30 UTR length of Stau2-regulated targets (overlap shown in A) compared to the rat genome. Note that only 23 of the 38 targets shown in (A) could be
used for this analysis due to incomplete database entries for the remainder (see Experimental Procedures). p < 0.0001, Wilcoxon rank sum test.
(C) Type III Staufen-recognized structures (SRSs) were mapped in the 30 UTRs of Stau2 targets and nontargets. The average number of Type III SRSs per
transcript and the frequency of SRSs are shown, both of which were significantly different between Stau2 targets (n = 20) and the rat 30 UTRome (n = 11,775).
Wilcoxon rank sum test p values are shown.
(legend continued on next page)
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one target, the regulator of G protein signaling 4 (Rgs4), which is
one of the synaptic mRNAs of the GPCR pathway and was
reduced by both Stau2 shRNAs to a statistically significant level
(reduced by 49% and 40% with shStau2-2 and shStau2-3,
respectively; Figure 4D). Note that shStau2-3 produces a stron-
ger knockdown when nucleofection or calcium transfection was
used, as compared to the viral-mediated knockdown shown
earlier (Figures S4A–S4C). The Rgs4 mRNA 30 UTR (ENSR-
NOG0000002773 in Figure S3A) contains two Type III SRSs.
This effect was further validated at the single-cell level using
Rgs4 FISH following Stau2 downregulation with shStau2-2 (Fig-
ure 4E) and shStau2-3 (data not shown), where the effect was
even more stark (Student’s t test p < 0.0001). Since there was
almost no Rgs4 left in the processes of Stau2-downregulated
neurons, only the cell body levels could be quantified.
To determine whether the observed reduction of Rgs4 mRNA
upon Stau2 knockdown is mediated via its 30 UTR, we generated
an Rgs4 30 UTR luciferase reporter and performed luciferase
assays in cortical neurons. Consistent with the reduction in
endogenous Rgs4 RNA we observed upon Stau2 knockdown,
Rgs4 reporter expression significantly decreased upon Stau2
downregulation with both shRNAs (Figure 4F). Together with
the qRT-PCR results, these findings suggest that Stau2 stabi-
lizes the Rgs4 mRNA via it’s 30 UTR.
CONCLUSIONS AND OUTLOOK
Here, we sought to identify physiologically relevant Stau2 targets
using a combined approach of immunoprecipitation of Stau2-
associated RNAs (to identify targets) together with the effect of
downregulation on those targets (to identify the role of Stau2 in
posttranscriptional regulation of these targets). While other
studies have identified candidate Stau2 targets, we found very
little overlap with our data set (Figure S4D), most likely because
the earlier studies did not fractionate Stau2-containing particles
away from ER. We believe that the more stringent approach
described here has yielded several insights into Stau2 function.
First, we have provided evidence for a role of Stau2 in the
stabilization of mRNAs as Stau2 targets were predominantly
downregulated in Stau2-deficient neurons. We note that the
levels of a small fraction of Stau2 targets increase upon Stau2
downregulation, consistent with a recent study in human cell
lines that implicates Stau2 in transcript destabilization (Park
et al., 2013). Although no such role of transcript stabilization
has been reported for Stau2 before, there is a recent publication(D) qRT-PCR of Stau2 and Rgs4 mRNAs following knockdown of Stau2 in cort
shStau2 samples were determined using the DDCT method and cross-normaliz
change ± SEM (n = 5). Significant differences were determined between shStau2
(E) Rgs4 FISH in primary hippocampal neurons following knockdown of Stau2. T
later for FISH. Antisense RNA probes were used to detect endogenous Rgs4mRN
indicated with an asterisk in the FISH image. Note that some bleed-through from t
underestimates differences in the quantification. Average cell body intensity o
neighboring untransfected cells. Bars represent the mean ratio of transfected
(shControl-2, n = 25; shStau2-2, n = 25). Scale bar, 10 mM.
(F) Dual luciferase reporter assay in cortical neurons. Renilla activity was normalize
to shControl-1 and the luciferase empty vector. Bars represent the mean relative lu
p values were calculated using the Student’s t test.
See also Figures S3 and S4 and Tables S5 and S6.
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showing a role in stabilizing differentiation mRNAs in human
keratinocytes (Kretz et al., 2013).
Second, our computational analysis of the Stau2 targets sug-
gests that it recognizes targets via secondary structures similar
to those that Drosophila Staufen recognizes in the 30 UTRs of
its targets (Laver et al., 2013). Given that the Rgs4 30-UTR con-
tains two such secondary structures (Type III SRSs) and together
with our finding that a reporter RNA carrying the Rgs4 30-UTR
behaves similarly to endogenous Rgs4 mRNA upon Stau2
knockdown, this supports the hypothesis that Stau2 regulates
its target RNAs by binding to type III SRSs in their 30 UTRs.
Thus, the secondary structures recognized by Staufen family
proteins may be conserved from flies to mammals.
Third, given that Rgs4 is a synaptic signaling molecule and
Stau2 downregulation has previously described synaptic pheno-
types (Goetze et al., 2006; Lebeau et al., 2011), misregulation of
Rgs4 following Stau2 knockdown could provide a mechanism
for the observed phenotypes. It is of particular note that Rgs4
has been linked to neuropsychiatric disorders (Terzi et al.,
2009), the stress response (Ni et al., 1999), and is responsive
to antidepressant drugs (Stratinaki et al., 2013). Therefore, regu-
lation by Stau2 would be of wide interest not only in the field of
RNA biology but also in clinical neurosciences.
Finally, it is very likely that mammalian Staufen proteins act as
multifunctional posttranscriptional regulators (St Johnston,
2005). In neurons, Stau2 likely plays a role in mRNA localization,
stability, and translation. Here, we focused on its effects on
mRNA regulation, uncovering a novel function in the stabilization
of steady-state levels of synaptic target RNAs, thus providing a
link between the molecular role of Stau2 as an RBP and its
cellular functions at the synapse.
EXPERIMENTAL PROCEDURES
Immunoprecipitations, RNA Isolation, and qRT-PCR
IPs were performed as described in RNase-free conditions on ice (Fritzsche
et al., 2013). RNA was isolated directly from beads and subjected to qRT-
PCR or microarray analysis in a minimum of three independent experiments.
Microarrays
For IP microarray analysis, RNA (200 ng) from input or IP was used for identi-
fying Stau2-associated RNAs. Preparation of terminal-labeled cDNA, hybridi-
zation to genome-wide GeneChip Rat Gene 1.0 ST Array (Affymetrix) and
scanning of the arrays were carried out according to manufacturer’s protocols
(https://www.affymetrix.com). Each IP as well as RNA isolated from the input
sample was analyzed from three biological replicates. Microarray data wereical neurons. Differences in steady-state RNA levels between shControl and
ation to the reference genes PPIA, Arntl, and Vinculin. Bars represent mean
and shControl samples using the Student’s t test. **p < 0.01, ***p < 0.001.
he 8 DIV neurons were transfected with the indicated shRNA and fixed 4 days
A and GFP antibodies to detect shRNA-transfected cells. Transfected cells are
he GFP staining leads to a diffuse signal in the FISH channel, which also slightly
f Rgs4 FISH signal was quantified from transfected cells and normalized to
to untransfected cells ± SEM taken from three independent experiments
d to Firefly to control for transfection efficiency. This ratio was then normalized
ciferase activity ±SEM (nR 4).Sepp1 is an unaffected Stau2-enrichedmRNA.
hors
analyzed with the R/BioConductor suite (http://www.bioconductor.org).
Robust multiarray analysis was used for normalization (Irizarry et al., 2003).
A linear model was used for inferring differential expression between groups
(Smyth, 2004). p values were adjusted using the Benjamini-Hochberg method
(Benjamini and Hochberg, 1995). For knockdown microarrays, the GeneChip
Rat Gene 2.0 ST Array (Affymetrix) was used. The experiment and analysis
were performed as described above.
FISH and Immunocytochemistry
FISH using tyramide signal amplification was performed as described previ-
ously (Vessey et al., 2008). The following RNA probes were used: Calm3 sense
and antisense from EST IMAGp998L0619945Q (accession number
AF231407), 1.3 kb from the 30 UTR of Calm3; Rgs4 (accession number
NM_017214) antisense probe in the first 1 kb of the 30 UTR, sense probe in
the last 1.3 kb of the 30 UTR. Immunocytochemistry was performed as previ-
ously described (Zeitelhofer et al., 2008). Images were acquired using an
Axioplan microscope (Zeiss) with a 633 planApo oil-immersion objective,
1.40 NA, and an F-view II charge-coupled device camera (Olympus). For
FISH following Stau2 knockdown, 8 days in vitro (DIV) primary hippocampal
neurons were transfected using calcium phosphate and fixed at 12 DIV.
Images were acquired using an Observer Z1 microscope (Zeiss) with a 633
planApo oil-immersion objective, 1.40 NA, and an CoolSnap HQ2 camera
(Olympus). Quantification of average cell body intensity was carried out using
Zen (Zeiss). An equal number of transfected and untransfected cells from each
coverslip (from three independent experiments) were quantified and the ratio
of transfected to untransfected used to determine differences between
shStau2 and shControl cells.
Antibodies
Monospecific Stau2 and Barentsz rabbit polyclonal antibodies were generated
in our laboratory by affinity purification from existing immune sera: Staufen2
antibodies were directed against the 62 kDa isoform of mouse Stau2
(Zeitelhofer et al., 2008), and anti-Btz antibodies were directed against the C
terminus of Btz (amino acids 356–527) (Macchi et al., 2003). The following
commercial antibodies were used: anti-phospho ERK1/2 (Cell Signaling
Technologies, 4370), anti-ERK1/2 (Cell Signaling Technologies, 4696),
anti-Tubulin (Sigma, clone B512) and anti-Vinculin (Santa Cruz, sc-7649).
Primary Neuron Culture
Embryonic day 17 (E17) hippocampal neurons were isolated from embryos of
timed pregnant Sprague-Dawley rats (Charles River Laboratories) as previ-
ously described (Goetze et al., 2006). Dissociated primary cortical neurons
were prepared from cortices remaining from hippocampal dissections. See
Supplemental Experimental Procedures for more information.
Lentivirus Production
For lentivirus production, HEK293-FT were transiently cotransfected
with psPAX2, pVSVg, and the shRNA constructs using Lipofectamine
2000 (Invitrogen). Supernatants were concentrated by ultracentrifugation
(22,000 rpm, 2 hr, SW28 rotor; Beckman Coulter). Virus particles were resus-
pended in Neurobasal medium (Life Technologies). Neurons were transduced
on day 2 and collected on day 5 for analysis (DIV 2+5).
Computational Analysis of Staufen Target 30 UTRs
WedownloadedRattus norvegicus (Rnor_5.0) cDNA sequences from Ensembl
using BioMart in August 2013 and defined 30 UTRs as the portion of the cDNA
30- to the open reading frame, as defined by Ensembl. When there were
multiple isoforms for a gene, we used the longest isoform to represent its
mature mRNA sequence. Then, to identify SRSs in these 30 UTRs, we followed
our previously described protocol (Laver et al., 2013). See Supplemental
Experimental Procedures for details.
Luciferase Assay
Gene fragments of interest were cloned downstream of the Renilla luciferase
gene into the psiCHECK-2 vector (Promega). As control, empty luciferase
reporter plasmidwas used. Rat primary cortical neurons (E17–E18) were trans-
fected with 5 mg of reporter plasmid and 25 mg of shRNA plasmid into 1.23 106Cell Recells and then distributed into six wells of a 24-well plate. Luciferase assays
were performed after 3 days using the Dual-Luciferase Reporter Assay System
(Promega) according to the manufacturer’s instructions using the GloMax
device (Promega). Ratios of Renilla/Firefly luciferase activity were calculated
and normalized to the shControl and the luciferase empty vector. The mean
of the normalized ratio from three or more independent experiments was
used to determine significant differences with the Student’s t test.
Further details are available in Supplemental Experimental Procedures.SUPPLEMENTAL INFORMATION
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Supplemental figures and legends 
 
Figure S1: Identification of Stau2 target RNAs from soluble Stau2 RNPs 
(Relates to Figure 1) 
(A) Immunoprecipitations for the RBP Barentsz were performed and the isolated 
mRNA analyzed by qRT-PCR. Six RNAs that are enriched in the Stau2 IP were 
tested for enrichment in Btz IP relative to the input sample. Sacm1l was the only 
mRNA that was significantly enriched in the IP compared to the control pre-
immune sera IP. Bars represent the mean enrichment from 3 independent 
experiments +/- SEM. Quantification of fold enrichment was cross-normalized to 
the reference genes GAPDH and PPIA.  
(B) Eight Stau2 target mRNAs (dark boxes) coding for Rgs4, Rgs2, the q/11 
subtype of the Gα G-protein (Gαq/11), Calmodulin (CaM), Calcineurin B subunit, 
RhoA, p63RhoGEF and CaMKIIβ have all been linked to a common GPCR 
signaling pathway. Signaling through Gαq/11 activates the MAPK cascade and can 
be inhibited by Rgs4 (Yan et al, 1997). Where the protein and RNA symbols 
differ, the RNA symbol is written in italics in parentheses. References for pathway 
interactions are: (Hague et al, 2005; Hao et al, 2006; Ishii et al, 2005a; Ishii et al, 
2005b; Lin, 2002; Lutz et al, 2005; Milligan & Kostenis, 2006; Yan et al, 1997). 
Enrichment of the individual RNAs in the Stau2 IP by microarray is indicated in 
the table.  
(C) The effect of Stau2 on ERK1 and ERK2 activation was tested by 
downregulation of Stau2 in primary cortical neurons. Plasmids expressing an 
shRNA targeting Stau2 or a non-targeting control shRNA were expressed in 
cortical neurons for 3 days, following which proteins were analyzed by Western 
blot. Phospho-specific or antibodies recognizing total ERK1/2 were used to detect 
active (phosphorylated) and total protein. Stau2 protein (four isoforms indicated) 
and Tubulin were detected to confirm knockdown efficiency. Note that all blots 
correspond to a single gel, however, intervening lanes were removed.  
(D) Quantification of Western blots from (B) of phospho-ERK1/2 relative to total 
ERK1/2. The mean +/- SEM from 3 independent experiments is shown. P-values 
were calculated using Student’s t-test. 
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Figure S2: Stau2 regulates mRNA levels in primary neurons (Relates to 
Figure 3) 
(A) Microarray analysis was performed on total RNA isolated from shStau2-v3 
and shControl-v2 transduced neurons. Significantly changed mRNAs are ordered 
by fold change in the knockdown relative to the control. Each dot represents a 
single mRNA with Stau2 being the most down-regulated RNA. 
(B) qRT-PCR validation of 8 mRNAs from the microarray. Relative levels of the 
indicated RNAs were determined in the shStau2-v2 knockdown relative to the 
control, shControl-v2, using cross-normalization to the reference genes Kif5c and 
PPIA. Bars represent the mean +/- SEM from 3 independent experiments.   
(D) Correlation between the validated targets shown in (B) and the fold change 
for the same targets according to the microarray (Pearson’s correlation 
coefficient, p< 0.001). 
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Figure S3: Mapping of Type III SRSs in the 3’-UTRs of Stau2 targets and 
non-targets (Relates to Figure 4).  
Type III SRSs were mapped in the 3’-UTRs of Stau2 targets (A), length-matched 
non-targets (B), and a random subset of non-targets (C). The x-axis represents 
the 3’-UTR in nucleotides, starting from the first nucleotide after the stop codon. 
Each 3’-UTR is represented by a grey bar within which the predicted Type III 
SRSs are represented by vertical red bars. For each SRS, the 5’-most nucleotide 
in the corresponding 10 of 12 motif hit is connected to its paired nucleotide in the 
partner arm by a line. In (A) the transcript identifier code is colored red if the 
transcript is downregulated or green if it is upregulated upon Stau2 KD. 
 
ENSRNOG00000019861
ENSRNOG00000011142
ENSRNOG00000002773
ENSRNOG00000016984
ENSRNOG00000006396
ENSRNOG00000000060
ENSRNOG00000015442
ENSRNOG00000009724
ENSRNOG00000008283
ENSRNOG00000010922
ENSRNOG00000010230
ENSRNOG00000008939
ENSRNOG00000014819 
ENSRNOG00000025061
ENSRNOG00000008374
ENSRNOG00000001035
ENSRNOG00000047620
ENSRNOG00000006604
ENSRNOG00000011944
ENSRNOG00000021025
ENSRNOG00000017444
ENSRNOG00000012685
500 nts
Type III SRS = [12,10,2] 
A
ENSRNOG00000024008
Upregulated in Stau2 KD
Downregulated in Stau2 KD
Figure S3A (Relating to Figure 4) 
(Rgs4)
ENSRNOG00000024863
ENSRNOG00000012397
ENSRNOG00000017404
ENSRNOG00000045825
ENSRNOG00000000070
ENSRNOG00000029336
ENSRNOG00000018481
ENSRNOG00000017484
ENSRNOG00000010601
ENSRNOG00000022772
ENSRNOG00000026403
ENSRNOG00000021133
ENSRNOG00000014746
ENSRNOG00000012840
ENSRNOG00000009995
ENSRNOG00000007284
ENSRNOG00000014456
ENSRNOG00000022466
ENSRNOG00000016960
ENSRNOG00000003476
ENSRNOG00000012603
ENSRNOG00000005981
ENSRNOG00000012873
500 nts
Type III SRS = [12,10,2] 
B
Figure S3B (Relating to Figure 4)
ENSRNOG00000001317
ENSRNOG00000010427
ENSRNOG00000012186
ENSRNOG00000006261
ENSRNOG00000010966
ENSRNOG00000020433
ENSRNOG00000014006
ENSRNOG00000017241
ENSRNOG00000000158
ENSRNOG00000001190
ENSRNOG00000019601
ENSRNOG00000000926
ENSRNOG00000005904
ENSRNOG00000003207
ENSRNOG00000002044
ENSRNOG00000020607
ENSRNOG00000016655
ENSRNOG00000019868
ENSRNOG00000002353
ENSRNOG00000014213
ENSRNOG00000009636
ENSRNOG00000004657
ENSRNOG00000032803
500 nts
Type III SRS = [12,10,2] 
C
Figure S3C (Relating to Figure 4)
 
Figure S4: Validation of Stau2 knockdown by shRNAs using nucleofection 
and calcium-based transfection in cortical neurons (Relates to Figures 4) 
(A-C) Validation of shRNA knockdown using nucleofection and calcium 
transfection. (A) Cortical neurons were transfected with the indicated shRNAs 
using nucleofection. After 3 days, protein samples were isolated for Western blot. 
Tubulin and Vinculin served as loading controls. The sequences targeting Stau2 
in shStau2-1 and shStau2-2 have both been published previously (Goetze et al., 
2006). shStau2-3 targets a third region of Stau2. shControl-1 (Stau2-2-mismatch 
control from (Goetze et al, 2006)) contains the shStau2-2 sequence but has 
several mismatches. ShControl-2 is a universal non-targeting control, and has no 
known complementary sequence in the mammalian transcriptome. pSuperior is 
the empty vector expressing no shRNA.  
(B) shRNAs were transfected into 8DIV hippocampal neurons, fixed at 11DIV and 
then immunostained with anti-Stau2 and Cy3-labelled anti-rabbit antibodies. GFP-
positive transfected cells are shown in the central images, and indicated by an 
asterisk next to the cell in the Stau2 immunostainings (outer images).  
(C) The intensity of Stau2 staining in the cell body in (B) was quantified in 
transfected and adjacent untransfected cells using Metamorph software (Roper 
Scientific, Visitron). Percentage change was calculated as the intensity of 
fluorescence of transfected cells relative to untransfected cells from the same 
experiment. Bars represent the mean +/- SEM of cells taken from 2 independent 
experiments (shControl-1 n=32, shControl-2 n=27, shStau2-2 n=8, shStau2-3 
n=12). Differences between controls and knockdowns were highly significant 
(Student’s t-test, p<0.001).  
(D) Comparison of the 38 Stau2-regulated targets identified in this study (see Fig. 
4A) to previously published Stau2 target datasets. 10 of the 38 RNAs were also 
found in the study by Maher-Laporte and Desgroseillers (2010), which was 
conducted by IP of endogenous Stau2 from unfractionated E17 rat brain. 5 RNAs 
were found with the study by Kusek et al. (2012), 2 of which were the same as 
those found by Maher-Laporte and Desgroseillers (Rgs4 and Ppp2r5b). This 
study was performed by IP of endogenous Stau2 from unfractionated E13 mouse 
brain. 5 different RNAs were found by Furic et al. (2008), 1 of which was shared 
with those also found by Maher-Laporte and Desgroseillers. This study was 
conducted in HEK-293 cells transfected by IP for over-expressed HA-tagged 
Stau262.  
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Supplemental Tables 
 
Table S1 – Stau2 IP microarray. mRNAs enriched more than 1.5-fold in the Stau2 
IP relative to input. Relates to Figure 1. See excel document Table S1. 
 
Table S2 - Full list of Stau2 target mRNAs validated by qRT-PCR for enrichment 
in the Stau2 IP. Relates to Figure 1 
Gene 
symbol 
 
Microarray 
Stau2 IP/ 
Input 
RT-qPCR 
Stau2 IP/ 
Input 
RT-qPCR 
Control IP/ 
Input 
Sepp1 4.38 6.25 0.70 
Sacm1l 4 10.44 1.40 
Comt 2.98 3.60 0.61 
Stx1a 2.8 3.44 0.90 
Sfrs3 2.77 1.69 0.43 
Rgs2 2.75 3.12 0.45 
Gna11 2.58 3.13 1.17 
Rgs4 2.3 2.59 1.11 
Lypla 2.3 2.04 0.71 
Prnp 2.21 0.84 0.53 
Cplx 2.2 1.47 1.02 
RhoJ 2.2 2.21 1.25 
RhoA 2.13 2.64 0.41 
Arpc4 1.92 1.52 0.41 
Calm3 1.91 4.34 0.41 
Nnat 1.77 5.85 0.31 
Camk2a 1.72 2.05 0.79 
Oprk 1.56 1.44 1.24 
Limk 1.56 1.37 1.45 
Actr2 1.55 1.31 0.66 
eIF4ebp2 1.47 0.87 1.21 
Septin9 1.3 1.59 0.90 
Arntl 1.23 0.68 1.03 
Calm1 1.23 1.29 0.55 
Actg 1.23 7.31 0.77 
Kif5c 1.16 1.23 1.10 
Map2 1.14 0.66 0.76 
Calm2 1.12 0.62 0.50 
Arc 1.08 1.52 4.57 
Cdc42ep2 1.05 0.64 0.43 
Usp7 1.02 0.56 0.96 
Ncam1 1.02 0.73 0.83 
Kcn2 1.02 0.64 0.41 
Cttnbp2 1.02 0.72 0.86 
ActB 0.93 0.41 0.48 
α-Tubulin 0.87 0.43 0.21 
Map1b 0.84 0.86 0.86 
Prox1 0.74 0.47 1.09 
Ift74 0.53 0.25 1.09 
Ndufa1 0.43 0.13 0.19 
 
 
Table S3 - Stau2-enriched targets cross-referenced to Cajigas et al (2012). All 
RNAs were cross-referenced to both the CA1 somatic layer and filtered neuropil 
layer. Relates to Figure 2. See excel document Table S3 
 
Table S4 – Stau2 knockdown microarray results. mRNAs significantly changed in 
shStau2-v2 relative to shControl-v2. Relates to Figure 3. See excel document 
Table S4. 
 
 
Table S5 – Overlapping RNAs between Stau2 IP and Stau2 knockdown 
microarrays. RNAs downregulated in the Stau2 knockdown are indicated in red, 
those that are upregulated are indicated in green. 
shSt2-2/ 
shControl-2 
Stau2 
IP/Input Gene Symbol Gene Description mRNA Accession 
0.265 2.20 Cplx1  complexin 1  NM_022864  
0.412 1.55 Ica1l  islet cell autoantigen 1-like  ENSRNOT00000041546  
0.473 1.55 RGD1559864  similar to mKIAA1045 protein  FQ211775  
0.486 1.95 Golph3l  golgi phosphoprotein 3-like  NM_001007698  
0.492 1.67 Nxph1  neurexophilin 1  NM_012994  
0.510 1.66 Nipsnap1  
nipsnap homolog 1 (C. 
elegans)  NM_001100730  
0.516 1.64 Nrsn1  neurensin 1  NM_001106109  
0.521 1.62 Gng7  
guanine nucleotide binding 
protein (G protein), gamma 7  NM_024138  
0.547 1.78 RGD1310127  
similar to cDNA sequence 
BC017158  BC099813  
0.567 1.66 B4galt5  
UDP-Gal:betaGlcNAc beta 
1,4-galactosyltransferase, 
polypeptide 5  NM_001108608  
0.572 2.30 Rgs4  
regulator of G-protein 
signaling 4  NM_017214  
0.578 2.16 Ppp2r1b  
protein phosphatase 2, 
regulatory subunit A, beta  NM_001025418  
0.581 2.14 Adck1  
aarF domain containing kinase 
1  NM_001108985  
0.597 1.74 Gtf2h3  
general transcription factor IIH, 
polypeptide 3  NM_001024236  
0.598 2.01 Thy1  Thy-1 cell surface antigen  NM_012673  
0.617 1.79 Snx10  sorting nexin 10  NM_001013085  
0.625 1.56 Ppp2r5b  
protein phosphatase 2, 
regulatory subunit B', beta  NM_181379  
0.628 1.83 Efr3b  
EFR3 homolog B (S. 
cerevisiae)  ENSRNOT00000039251  
0.640 1.61 Sdc1  syndecan 1  NM_013026  
0.641 1.75 Ift52  
intraflagellar transport 52 
homolog (Chlamydomonas)  NM_001177685  
0.642 1.56 Atg13  autophagy related 13  ENSRNOT00000023237  
0.657 1.92 Tstd2  
thiosulfate sulfurtransferase 
(rhodanese)-like domain 
containing 2  NM_001108663  
0.664 1.99 Fam45a  
family with sequence similarity 
45, member A  NM_001127681  
0.670 2.14 Sft2d2  SFT2 domain containing 2  NM_001034011  
0.676 1.89 Sfxn3  sideroflexin 3  ENSRNOT00000021171  
0.678 1.60 Srebf2  
sterol regulatory element 
binding transcription factor 2  ENSRNOT00000056041  
0.683 2.39 Cyb5b  
cytochrome b5 type B (outer 
mitochondrial membrane)  NM_030586  
0.690 1.60 Nmt2  N-myristoyltransferase 2  ENSRNOT00000030219  
0.707 1.67 St6galnac3  
ST6 (alpha-N-acetyl-
neuraminyl-2,3-beta-
galactosyl-1,3)-N-
acetylgalactosaminide alpha- NM_019123  
2,6-sialyltransferase 3  
0.718 1.95 RGD1305587  
similar to RIKEN cDNA 
2010107G23  BC158618  
0.719 1.53 Negr1  neuronal growth regulator 1  NM_021682  
0.720 2.11 Tollip  toll interacting protein  NM_001109668  
1.358 1.57 Rwdd4  RWD domain containing 4A  NM_001034994  
1.359 1.99 RGD1308106  LOC361719  NM_001134575  
1.481 2.00 Cdc25c  
cell division cycle 25 homolog 
C (S. pombe)  NM_001107396  
1.593 2.10 LOC302495  hypothetical LOC302495  NM_001106950  
 
 
Table S6 – Sequences and Structures surrounding SRSs in Stau2 target mRNAs. 
We show the sequences for the SRS matches (in uppercase) and the 150nt-long 
(if applicable) flanking sequences on either side of each match. We also show the 
centroid structure predicted for these regions. See excel document Table S6. 
 
Extended experimental procedures 
 
Plasmids and shRNAs 
shRNA plasmids were cloned into the pSuperior+GFP vector system according to 
manufacturer’s instructions (Oligo Engine). The targeting sequences were as 
follows: shStau2-1 5’ GCCCTACAGAATGAGCCAA 3’, shStau2-2 5’ 
GATATGAACCAACCTTCAA 3’, shStau2-3 5’ CCGTCAGTTTTGAGGTTAT 3’, 
shControl-1 5’ GATATGAAACCCCACTTAA 3’, shControl-2 5’ 
TAAGGCTATGAAGAGATAC 3’. shStau2-2 and shControl-1 (shStau2-2mis) have 
been previously described (Goetze et al, 2006). For lentiviral-mediated 
knockdown, the shControl-1, shStau2-2 and shStau2-3 expression cassette (H1 
promoter + shRNA) were subcloned from pSuperior into a lentiviral vector, FUW 
(Lois et al., 2002) coexpressing TagRFP driven by human ubiquitin C promoter. 
These sequences are denoted with shStau2-v2 and -v3. shControl-v1 
corresponds to the shControl-1 sequence, whereas shControl-v2 targets the 
luciferase gene with the sequence (5’-CGTACGCGGAATACTTCGA-3’).  
Full-length Rgs4 3’-UTR was PCR amplified from a rat EST plasmid obtained 
from Imagenes (IMAGp998K1715372Q) using the primers: Fwd, 
GTCAAAGTCGACTTCTCACACAGAGGCAGAGAACCGAAATGCCAAGACTCT
ATGCTCTGGAAAACCTG;Rev,GAACATGCGGCCGCGTAGGAAGCATTTATTT
CCTGTTATC and cloned into psiCheck-2 (Promega) dual luciferase reporter 
plasmid via SalI/NotI. The Sepp1 3'-UTR luciferase reporter was subcloned from 
Imagenes EST plasmid (IRQLp5017G0112D) using NotI/XbaI restriction sites. 
For Rgs4 antisense FISH probe, a portion of Rgs4 3’-UTR was PCR-amplified 
from rat genomic DNA and cloned into pGEM-T using the following primers: 
Fwd,TCTCACACAGAGGCAGAGAACC; Rev, TCCTCTCAAACATCCATCTCCA. 
 
Primary neuron cultures and transfections 
Embryonic day 17 (E 17) hippocampal neurons were isolated from embryos of 
timed pregnant Sprague Dawley rats (Charles River) as previously described 
(Goetze et al, 2006). Dissociated primary cortical neurons were prepared from 
cortices remaining from hippocampal dissections (E17 Sprague Dawley rats). 
Cortices were cut up and treated with 0.05% trypsin for 10 minutes, then triturated 
in DMEM+HS using a 1mL pipette and fire-polished Pasteur pipettes, then filtered 
consecutively through 100uM and 70uM filters. Cells were counted, transfected 
using the Amaxa Nucleofection™ device (see below) and plated directly onto 
Poly-L-lysine coated cell culture dishes.  
Primary hippocampal neurons used for imaging of shRNA knockdown efficiency 
and FISH were transfected using calcium phosphate precipitation as previously 
described (Köhrmann et al, 1999). Cortical neurons were transfected using the 
Amaxa Nucleofection™ device (Rat Neuron Nucleofector Kit, Lonza, program O-
003 or AK-009). Procedures were carried out as previously described (Zeitelhofer 
et al, 2007). Up to 4 million cells were transfected with 30µg of plasmid DNA and 
plated at a density of 1.5-2 million cells per 6cm dish. RNA or protein was isolated 
3 days later.  
Isolation of RNA from Stau2 RNPs 
IPs were performed as described in RNase-free conditions on ice (Fritzsche, 
Karra et al., Cell Reports, accepted). Briefly, E17 rat brains were homogenized in 
extraction buffer (EB; 25 mM HEPES (pH 7.3), 150 mM KCl, 8 % glycerol, 0.1 % 
NP-40, 40U/ml RNase inhibitor, 1 mM DTT, protease inhibitor cocktail) and 
centrifuged at 20,000g. The S20 was fractionated over a 15-30% Optiprep™ 
(Axis-Shield) density gradient that was centrifuged in a swinging bucket rotor 
(SW41, Beckman) at 280,000 x g at 4°C for 2.5 hours. 900µL fractions were 
removed and analyzed for Stau2, calnexin and ribosomal proteins by Western 
blot. Four fractions (F4-7) enriched for Stau2 but mostly depleted of calnexin were 
pooled and used as input for the IP. Input was pre-cleared with protein A beads 
before IP and 50µl was set aside for RNA isolation. Protein A beads coupled to 
an equal amount of either affinity-purified Stau2 (or Barentsz) antibodies or rabbit 
pre-immune serum were blocked with BSA and then incubated with the input for 2 
hours rotating at 4°C. Following binding, the beads were washed 2 times in EB 
supplemented with an extra 0.4% NP-40, 2 times in EB and 2 times in 5mM Tris, 
100mM NaCl.  
 
Total RNA was isolated using miRvana™ miRNA isolation kit according to 
manufacturers instructions (Applied Biosystems). For the first step, the lysis and 
binding buffer was added directly to the compacted IP beads after removal of the 
final wash. RNA was eluted from the column with 100µL nuclease-free H2O and 
ethanol precipitated. The final RNA pellet was resuspended in 12µl nuclease-free 
H2O and the concentration measured using a NanoDrop spectrophotometer 
(Thermo Scientific). RT-qPCR was performed (see below) on a minimum of 3 
independent IPs for any given RNA and significance determined using Student’s 
t-test (P<0.05) 
 
RNA/protein isolation from lentiviral transduced neurons 
Transduced neurons were harvested at 7DIV to isolate RNA and protein samples. 
RNA was isolated using RNeasy kit with on-column DNase digestion (Qiagen) 
according to the manufacturer’s instructions. Protein lysates were collected by 
washing the neurons first in warm HBSS and then lysing directly in 2 x Laemmli 
buffer. The lysate was boiled for 5mins at 95oC and then freeze-thawed once 
before Western blotting was performed.  
cDNA synthesis and quantitative RT-PCR 
RNA samples (0.5-2µg) were treated with DNase I to remove contaminations. 
Following this, cDNA was synthesized from 0.5-1µg DNase-treated RNA using 
random primers and Superscript III™ reverse transcriptase (Invitrogen) according 
to the manufacturer’s instructions. For IPs, 0.5 µg of input RNA, 0.5 µg of IP RNA 
and an equal volume of pre-immune IP RNA was used as template. Quantitative 
reverse transcriptase PCR (RT-qPCR) of mRNAs was performed using the SYBR 
green mastermix (Bio-Rad) according to manufacturers instructions. 3µl of a 1:10 
dilution of cDNA was added to each 25µl reaction, in triplicate for each primer set. 
For non-template controls (NTC), ddH2O was used in place of the cDNA. All RT-
qPCR data were analyzed using the comparative ΔΔCT method (Schmittgen & 
Livak, 2008). Primer sets were rigorously validated on dilution series and 
optimized to achieve 95-105% efficiency before use. For each new experiment, 
several potential reference genes were tested for stable expression between 
samples. To avoid any potential bias introduced by a single reference gene, 
cross-normalization to at least two reference genes was used (Weidensdorfer et 
al., 2009). Reference genes used for each experiment are indicated in the 
corresponding figure legend. 
GO term analysis 
GO term enrichments were determined using DAVID 
(http://david.abcc.ncifcrf.gov) (Huang et al, 2009). For the IP, RNAs that were 
enriched greater than 1.5-fold relative to input were used for the analysis. For the 
knockdown microarray, all significantly up- (99) and down-regulated (349) genes 
were used for the analysis. 
Gene symbols were used to compare the RNAs found in this study with those 
previously published. Mouse and human symbols were converted to rat where 
necessary using MammalHom 
(http://depts.washington.edu/l2l/mammalhom.html).  
 
Western blots  
Equal amounts of protein were separated via SDS-PAGE and subjected to 
immunoblotting. For phospho-ERK Western blotting, equal numbers of primary 
cortical neurons were transfected and plated. Cells were washed in HBSS and 
directly lysed and scraped from the dish in Laemmli buffer, boiled and an equal 
volume was used for SDS-PAGE. Membranes were blocked using 1 x Detector™ 
Block (KPL) solution, or 5% BSA in 1xTBS/0.1% Tween-20 (TBST) for phospho-
ERK antibodies, for at least 30 min at room temperature. Primary and secondary 
antibodies were diluted in blocking solution. The membrane was incubated with 
the primary antibody for 2 hours at room temperature or overnight at 4°C. 
Secondary antibodies were conjugated to the IRDye700 or -800 and incubated 
with the membrane for 1 hour protected from light. All washes were performed in 
PBS/0.1% Tween except for ERK antibodies where TBST was used. Following 
washes, the membrane was scanned with the infrared-based Odyssey Imaging 
System (Li-Cor). Western Blot bands were quantified using ImageJ software 
(http://rsbweb.nih.gov/ij/index.html). 
 
Identification of Staufen recognized structures (SRSs) 
We downloaded Rattus norvegicus (Rnor_5.0) CDNA sequences from Ensembl 
using BioMart in August 2013 and defined 3’-UTRs as the portion of the cDNA 3’- 
to the open reading frame, as defined by Ensembl. When there were multiple 
isoforms for a gene, we used the longest isoform to represent its mature mRNA 
sequence. Of the 38 ‘high-confidence’ genes identified by IP, 23 were analyzed 
for SRSs; the remainder were missing due to suspected off-target effects of the 
control or Stau2 shRNA (three transcripts), ID matching (four transcripts) or 
sequence unavailable (eight transcripts). Then, to identify SRSs in these 3’-UTRs, 
we followed our previously described protocol (Laver et al., 2013). Briefly, we 
annotate double-stranded RNA (dsRNA) stems using the annotation [M,N,U], 
where at least one arm is exactly M nucleotides long and the stem contains at 
least N canonical base pairs (i.e., Watson–Crick or G-U wobble base pairs) with 
the nucleotides in the other arm, including the bases at the 5’- and 3’- ends of the 
stem. Furthermore, both arms include at most U unpaired nucleotides (i.e., have 
no partner base on the opposite strand and thus are unable to form either a 
canonical or a non-canonical base-pair). We performed a two-step procedure to 
identify the SRS matches, where we first scan the 3’-UTRs to look for regions that 
are highly paired and then fold locally around those regions to identify appropriate 
stems. Taking the Type III SRS, [12,10,2], as an example, we first applied 
RNAplfold (Bernhardt et al., 2006) and calculated the single-nucleotide base-
pairing probability for the entire rat 3’-UTRome, using the parameter settings W = 
200, L = 150 and U = 1 as suggested (Lange et al., 2012). We then estimated the 
probability that 10 bases in each 12 nucleotide region participate in a canonical 
base pair using the lowest single-nucleotide probability from this region, after 
removing the two (i.e., 12-10) nucleotides with the lowest single-nucleotide 
probability among all of the nucleotides in the region except the bases at the 5’- 
and 3’-end of the region. We selected all the 10 of 12 motif hits within the top 1% 
of the 10 of 12 probabilities across all rat 3’-UTRs. We then folded these hits 
together with 150nt-long flanking sequences on either side of each hit, using 
Sfold (Ding & Lawrence, 2003). Based on the centroid structure predicted by 
Sfold, we selected matches to the Type III SRS from the 10 of 12 motif hits, 
based on the following four criteria: (i) at least 10 of the 12 bases in the 10 of 12 
motif hit had to be paired, including the first and last bases; (ii) the hit’s ‘partner 
region’, which is the transcript sequence between the bases that pair with the first 
and last bases of the 10 of 12 motif hit, had to pair only with bases in that hit (i.e., 
contain no hairpins); (iii) the motif hit had to pair only with bases in its partner 
region; and (iv) the 10 of 12 motif hit and its partner region together had at most 
two bases that neither formed a canonical base pair nor a non-canonical base 
pair (i.e., were unpaired). 
We scored the enrichment of the Type III SRS in two ways: Firstly, the frequency 
of Type III SRSs per 3’-UTR and, secondly, the frequency of Type III SRSs per 
nucleotide (i.e., normalized to 3’-UTR length). The expected baseline rates were 
calculated using the entire rat 3’-UTRome. We performed the two-tail Wilcoxon 
rank sum test to evaluate the significance of the enrichment for Type III SRSs in 
the Stau2 targets relative to the baseline.   
RT-qPCR primers (Relates to Figures 1 and 4) 
Gene Sequence 5' to 3' 
γ actin fwd CTTCCAGCAGATGTGGATCA 
γ actin rev CCAGGGAAATCGATACTTC 
Actr2 fwd GCTGGCCTTAGAGACCACAG 
Actr2 rev AAGCAATTCAGCAACACCAA 
Ago1 fwd CAACATCACTCACCCGTTTG 
Ago1 rev GCAGGTGCTGGGATAGAGAC 
Arc fwd AGAACGACACCAGGTCTCAA 
Arc rev CCTATTTTCTCTGCCTTGAAA 
Arntl fwd TTAGCCAATGTCCTGGAAGG 
Arntl rev CCTGGAACAGTGGGATGAGT 
Arpc4 fwd TTCGAAGGAAACCTGTGGAG 
Arpc4 rev GGAACTCCTCAGCCACGATA 
β actin fwd GTCCACCTTCCAGCAGATGT 
β actin rev GAAAGGGTGTAAAACGCAGC 
Bicd2 fwd AAGGAAGCACTCATGGAGGA 
Bicd2 rev GTCACCATGGCCTTCTCATT  
Calbindin fwd CTGACAGAGATGGCCAGGTT 
Calbindin rev GGCATCCAGCTCATTTTCAT 
Calm3 fwd ACAGCGAGGAGGAGATACGA 
Calm3 rev CATAATTGACCTGGCCGTCT 
CaMKIIα fwd AAACTGAAGGGAGCCATCCT 
CaMKIIα rev TCCATTGCTTATGGCTTCGATC 
Comt fwd GAGCTGGGAGCTTACTGTGG 
Comt rev CCCATTGAGGATGGTGACTT 
Cplx1 fwd GAGGCAGAACGTGAGGTCAT 
Cplx1 rev GAGTCAGGCTGCCTTCTGAG 
Dicer1 fwd GCAAGGAATGGACTCTGAGC 
Dicer1 rev GTACACCTGCCAGACCACCT 
eIF4ebp2 fwd GCGCAGCTACCTCAGGACTA 
eIF4ebp2 rev CGACGGTCCAACAGAAACTT 
Fez1 fwd TCTTCTCCTCCCTCTGTGGA 
Fez1 rev GCAAAGTAGGCACCTTCTCG 
Gabarapl2 fwd CCCATCTGACATCACTGTGG 
Gabarapl2 rev TTAGGCTGGACTGTGGGACT 
GAPDH fwd ATTCTTCCACCTTTGATGC 
GAPDH rev GTCCACCACCCTGTTGCTGTA 
Ift74 fwd CAAATGACTGCTGACCTGGA 
Ift74 rev AGGCATTTCTGTGGGTTGAC 
Kif5c fwd AACCTGGAGCAGCTTACCAA 
Kif5c rev CAGTAGCACGGAGCCTCTTC 
Limk1 fwd CCTCCGAGTGGTTTGTCGA 
Limk1 rev CAACACCTCCCCATGGATG 
Lypla1 fwd GCCTTCGCAGGTATCAAAAG 
Lypla1 rev TTCATCCTCCTGGGAATCTG 
Map1b fwd TGCTTCTGCATCCAAGTCAG 
Map1b rev TGTTGCTGTGGTTGGGAATA 
Map2 fwd GGAAGAAGCCTCGAAGATGGAA 
Map2 rev TGGGGAGTTTTACTTGTGTCCG 
Ncam1 fwd AACGGACTCCAAACCATGAC 
Ncam1 rev TGGCTTTGCTTCTGACTCCT 
Ndufa1 fwd CATCCACAAGTTCACCAACG 
Ndufa1 rev CAGGCCCTTGGACACATAGT 
Nnat var.1 fwd TCATCATCGGCTGGTACATC 
Nnat var.1 rev CTGTGTCCCTGGAGGATTTC 
Oprk1 fwd TTCCCTGGTCATGTTTGTCA 
Oprk1 rev CATCTCCAAAAGGCCAAGAA 
PPIA fwd GTC AAC CCC ACC GTG TTC TT 
PPIA rev CTG CTG TCT TTG GAA CT TTG 
Ppp2r1b fwd CAGCTGGGTGTGGAGTTTTT 
Ppp2r1b rev CATGAGGTTGTTGGTTGCTG 
Ppp2r5b fwd CATTTCCAGGTTGCAGAGCG 
Ppp2r5b rev ACAGTGTGGCAGTTGTCCTC 
Prnp fwd TAGGAGAGCCAAGCCGACTA 
Prnp rev CTTTTTGCAGAGGCCAACAT 
Rgs2 fwd AATATGGGCTTGCTGCATTC 
Rgs2 rev TGGGAGCTTCCTTCTCGAT 
Rgs4 fwd AGTCCCAAGGCCAAGAAGAT 
Rgs4 rev AACATGTTCCGGCTTGTCTC 
RhoA fwd AAGGACCAGTTCCCAGAGGT 
RhoA rev TGTCCAGCTGTGTCCCATAA 
RhoJ fwd TCATTGGGACCCAGATTGAT 
RhoJ rev GGCAGAGCATTCCAAGTAGC 
Sacm1 fwd AAGTGTTCCAAGGGACTGGA 
Sacm1 rev CTTGCAACTCCCCAGAAGAG 
Sepp1 fwd GGCCGTCTTGTGTATCACCT 
Sepp1 rev TGAAAGAGCAGTTTCCACACC 
Sept9 fwd GGATTCTGGGAAGGAAGACC 
Sept9 rev AGGCTTCGAAGTGGATGTTG 
Stau2 fwd GAACATCTCCTGCTGCTGAAG 
Stau2 rev ATCCTTGCTAAATATTCCAGTTGT 
α-Tubulin fwd  TGTCTTCCATCACTGCTTCC 
α-Tubulin rev  TGTTCATGGTAGGCTTTCTCAG 
Uhmk1 fwd TCCTGGCAGAGGACAAGTCT 
Uhmk1 rev CCCTCTTGTAGGCACTCAGC 
Vinculin fwd TCACAGTGGCAGAGGTAGTG 
Vinculin rev TGACAGTGTTCATTGAGTTC 
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AP5/APV – (2R)-amino-5-phosphonovaleric acid 
APA – Alternate poly-adenylation 
APS – ammonium persulfate 
AS – Alternative splicing 
Btz – Barentsz 
CA1 – Cornu Ammonis 1 
CaM/Calm – Calmodulin 
CaMKII – Calcium/Calmodulin Kinase II 
cDNA – complementary DNA 
CDS – coding sequence 
CNQX – 6-cyano-7-nitroquinoxaline-2,3-dione 
CPEB – cytoplasmic polyadenylation-element-binding protein 
Cplx1 – Complexin 1 
Crm1 – Chromosomal Maintenance 1 
DAPI – 4',6-diamidino-2-phenylindole 
DIV – days in vitro 
dsRBD – double-stranded RNA-binding domain 
dsRBP – double-stranded RNA-binding protein 
dsRNA – double-stranded Ribonucelic acid 
DTT – Dithiothreitol 
E/GFP – enhanced / green fluorescent protein 
E17 – embryonic day 17 
EJC – exon-junction complex 
ER – endoplasmic reticulum 
ERK – Extracellular signal Regulated kinase 
EV – empty vector 
FISH – Fluorescent in situ hybridisation 
FMRP – Fragile X Mental Retardation Protein 
FUS – Fused in Sarcoma 
GO – Gene ontology 
GPCR – G-protein coupled receptor 
GFP – Green Fluorescent protein 
iCLIP – individual-nucleotide resolution Cross-Linking and ImmunoPrecipitation 
IgG – immunoglobulin 
IP – Immunoprecipitation 
IR – Intron retention 
ISH – In situ hybridisation 
kb – kilobases 
KD – knockdown 
LE – Localization element 
LTD – Long-term depression 
LTP – Long-term potentiation 
MAP2 – microtubule-associated protein 2 
MCS – multiple cloning site 
mEPSC – miniature excitatory postsynaptic current 
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mGluR – metabatropic glutamate receptor 
miRNA – microRNA 
mRNA – messenger RNA 
NCBI – National Centre for Biotechnology Information 
NLS  – Nuclear localization signal 
NMD – Non-sense mediated decay 
NMDA – N-Methyl-D-aspartic acid 
nt – nucleotides 
NTC – Non template control 
OE – overexpression 
oligo(dT) – oligonucleotide deoxythymidine 
O/N – Overnight 
ORF – open reading frame 
PACT – protein activator of the interferon-induced protein kinase 
PAGE – polyacrylamide gel electrophoresis 
PIS – pre-immune serum 
PKMζ – Protein Kinase M, zeta 
PPIA – Peptidylprolyl isomerase A 
PTC – Premature termination codon 
Pum2 – Pumilio 2 
qRT-PCR - quantitative reverse transcriptase (real-time) PCR 
RBD – RNA-binding domain 
RBP – RNA-binding protein 
RCN – Rat cortical neurons 
RFP – red fluorescent protein 
Rgs – Regulators of G-protein signalling 
RhoA – ras homolog gene family, member A 
RISC – RNA-induced silencing complex 
RNAi – RNA interference 
RNP – Ribonucleoprotein particle 
RT – reverse transcription 
SDS-PAGE – Sodium dodecyl sulfate polyacrylamide gel electrophoresis 
SEM – Standard error of the mean 
shRNA – short hairpin RNA 
siRNA – short-interfering RNA 
snoRNA – small nucleolar RNA 
snRNA – small nuclear RNA 
SRS – Staufen recognized structure 
SSC – saline-sodium citrate 
Stau – Staufen 
TDP – TAR DNA-binding protein 
Tm – melting temperature 
TRBP – TAR RNA-binding protein 
tRNA – transfer RNA 
TTX – Tetrodotoxin 
UCSC – University of California, Santa Cruz 
UTR – untranslated region 
YFP – yellow fluorescent protein 
ZBP1 – Zipcode-binding protein 
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